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CHAPTER ONE 
GENERAL INTRODUCTION 
1.1 GENERAL 
1.1.1 principles of Immunoassay 
The basic principles of immunoassay were first 
reported by Berson and Yalow (1959) and since then it 
has become an extremely powerful technique in the 
determination of a broad spectrum of compounds. The 
power of the technique lying chiefly in the areas of 
specificity and versatility. 
The principles of immunoassay are basically 
straightforward. If the substance of analytical 
interest is foreign to an animal, typically a rabbit, 
sheep or goat, injection of that substance into the 
animal will cause the production of a glycoprotein, 
known as an antibody (Ab). The antibody produced will 
have a specificity for the substance that initiated its 
production, the antigen (Ag). Antigens are generally 
naturally occur~ng macromolecules, e.g., proteins, 
polysaccharides, nucleic acids, etc. Smaller molecules, 
e.g., drugs, hormones, peptides, etc., do not 
themselves initiate antibody production, but when 
coupled to a macromolecular carrier, e.g., a protein or 
a synthetic polypeptide, antibody production may be 
initiated. The resultant antibodies will react with the 
carrier linked molecule and also the small molecule 
alone. A small molecule of this type is known as a 
hapten. 
Immunoassay is 
hapten)-antibody . binding 
based on 
reaction 
reversible and non-covalent: 
Ag + Ab ~ Ag-Ab 
the antigen 
which is 
(or 
both 
If a label (see Chapters 3 and 5) is covalently 
attached to the antigen in such a way that it does 
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not block the reaction site for the antibody, the 
presence of the label will not significantly effect the 
binding reaction. Thus, in a situation in which a 
mixture of labelled (Ag*) and unlabelled (Ag) antigen 
react with antibody competition for the antibody 
binding site occurs: 
Ag* + Ag + Ab ~ Ag*Ab + AgAb 
Using labelled antigen (Ag*) it is possible to 
determine an unknown amount of antigen in a given 
solution. If a competitive binding reaction between Ag 
and Ag* is set up and allowed to reach equilibrium, the 
amount of labelled antigen-antibody complex will 
decrease for a fixed amount of labelled antigen with 
increasing unlabelled antigen concentration in the 
reaction mixture. The measurement of some property 
proportional to the amount of antigen-antibody is used 
to construct a curve where the property measured is 
plotted as a function of unlabelled antigen 
concentration. A typical example of this type of curve 
is shown in Fig. 1.1: 
Antigen Concentration 
Figure 1.1 
A 'typical calibration curve for immunoassay 
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The unknown antigen concentration in a given 
sample may thus be determined from a competitive 
binding reaction with known amounts of labelled antigen 
and· antibody,. the antigen content subsequently being 
determined from the standard curve. 
An alternative approach to immunoassay was 
described by Miles and Hales (1968) and termed 
immunoradiometric assay (IRMA), (since it initially 
used isotopically labelled antibodies). In this type of 
assay the labelled component is a specific antibody 
(Ab*), the process again being based on the antigen 
antibody binding reaction: 
Ag. + Ab + Ab* Ag-Ab + Ag-Ab* 
This method may now become more important with 
the introduction of monoclonal antibodies (Koprowski 
et. al., ·1977; Albertini and Ekins, 1981) as these 
offer a more specific antigen-antibody binding 
reaction. In this case the antibody is specific to a 
given substance rather than a serum containing a 
mixture of antibodies reacting with the substance. The 
major disadvantage of monoclonal antibodies, however, 
lies in the increased cost of the product. 
Immunoassays may generally be divided into two 
distinct types: heterogeneous assays, where a 
separation step is necessary to separate antibody bound 
and unbound materials, and homogeneous assays, in which 
no separation step is required. 
The major advantages of immunoassay, are its 
specificity, versatility and sensitivity. Specificity 
and versatility may be attributed to the selective and 
specific nature of the antigen-antibody binding 
reaction and the large number of molecules of interest 
that themselves, or coupled to a carrier (i.e., 
haptens) may be used to initiate antibody production. 
Page 3 
The sensitivity of an immunoassay procedure is 
dependent upon the choice of label and its limit of 
detection in the matrix of interest. Typical 
radioimmunoassay procedures have limits of detection in 
the p mol l-Irange, while an enzymatic immunoassay for 
macromolecular analytes reported by Ishikawa and Kato 
(1978) has a reported sensitivity of 10 -18 moles 
1.1.2 Radiolabels : Advantages and Disadvantages 
In the original immunoassay of Yalow and Berson 
(1960), the label of choice was a radioisotope ( 1251) 
and today radioisotopes are still widely used as labels 
(The Immunoassay Index I Anon. Lab .. Pract. (1983), 
32(8), 21), 125 1 being the most commonly used. 
Radioimmunoassay (RIA) has been used extensivelY in the 
determination of steroid and peptide hormones, drugs 
(both for therapeutic monitoring and for the detection 
of drugs of abuse) and various macromolecules of 
clinical interest. 
The principal advantages of radioimmunoassay are 
the selectivity of the assay, conferred as in all 
immunoassays by the specificity of immunological 
.reactions, and the sensitivity of radioisotope 
determination. The latter is the factor that has led to 
RIA becoming the most extensively used form of 
immunoassay, as background interference is not a 
problem. 
However, RIA does have several major 
disadvantages which have led to extensive research into 
the use of alternative labels. The most important of 
these include: (i) the inherent instability of 
radiolabelled compounds, (ii) the need for specialised 
equipment and associated safety precautions, (iii) the 
cost of preparing radiolabelled compounds, (iv) all 
RIA's are heterogeneous because the properties of the 
label do not change on Ag-Ab binding, hence a 
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separation step must be included. The nature of the 
separation step, which could be: (i) adsorption, e.g. 
onto charcoal, ( ii) the use of a second, -
precipitating, antibody which forms an insoluble 
complex with the antigen I hapten-antibody complex, 
(iii) the use of solid phase antibodies, e.g., 
antibodies adsorbed or covalently linked orito the walls 
of polystyrene tubes or magnetic particles, is 
generally such that automation is difficult on a small 
scale, (v) disruption of the reaction by radioactivity. 
Although RIA has the distinct advantages (over 
alternative labels) associated with the determination 
of radioisotopes in general (high sensitivity, low 
background inteference), the last decade has seen 
extensive research into the development of alternative 
(non-isotopic) labels (which may be measured with 
similar sensitivity) designed to overcome the problems 
listed above. 
1.1.3 Non-Isotopic Immunoassay 
A General Discussion 
The problems associated with RIA, as discussed 
earlier, have led to extensive research into the field 
of non-isotopic immunoassay, where a safer and more 
conveniently detectable label replaces the radiolabel. 
Perhaps the most important factor to be 
considered in the choice of a label for a non-isotopic 
immunoassay procedure is the level at which it can be 
detected in the biological samples, (e.g., blood serum) 
used in immunoassay, as this is the area in which the 
power of RIA lies. A summary of, the cr iter ia to be 
considered in label and method choice is given in Table 
1.1: 
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Table 1.1 
criteria for an ideal label and method for non-isotopic 
immunoassay: 
1. Freedom from hazards; 
2. Ease of introduction into sample molecules; 
3. cost and availability of appropiate instrumentation; 
4. No effect on Ag-Ab reaction; 
5. Free from inteference from biological samples; 
6 •. Low cost, easy availability and long term stability; 
7. Suitability for homogeneous assays and automation; 
8. Possibility of combination with another label to 
develop a multi component analysis. 
The alternative labels investigated to date have 
met with varied success. Table 1.2 lists reviews of 
non-isotopic immunoassay labels with general comments 
and examples. 
Of the alternative labels, enzymes and the 
methods of enzyme immunoassay have been widely 
investigated and have met with·much commercial success. 
One of the initial practical alternatives to RIA was 
that of Rubenstein et. al. (1972) with the introduction 
of a homogeneous enzyme immunoassay. Since this time 
the number of methods has increased dramatically and 
the EMIT and ELISA techniques are now well established 
methods. A large number of heterogeneous methods are 
now available comercially (Schall and Tenso, 1980) and 
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Immunoassay 
Type 
Enzyme 
'"Cl Immunoassay PJ 
<!l 
ro 
..., 
Co-Enzyme 
Immunoassay 
Chemiluminescence 
and 
Bioluminescence 
Immunoassay 
Table 1.2 
A Review of non-isotopic immunoassay procedures 
Label(s) 
Enzymes • 
NAD 
ATP 
Chemiluminescent 
groups 
Detection 
Method 
(1) spectrometry 
(11) fluorimetry 
spectrophotometry 
luminometry 
Comments 
homogeneous methods; 
commercially available 
methods; cost may be a 
disadvantage; enzymes 
are labi le 
complicated labelling; 
simple, but often 
imprecise detection 
complicated 
labelling; detection 
simple, but time 
dependent; low 
detection limits 
possible; homogeneous 
methods 
Reviews and Examples 
Schuurs and van Weeman, 
1980; 
Ishikawa et. al., 1981; 
Carrico et. al., 1976(a); 
Carrico et. al., 1979(b) 
. Gorus and Schram, 1979; 
Schram and Stanley, 1979; 
Whitehead et. al., 1979; 
Wilson, 1980; 
Deluca and McElroy, 1981; 
Olsson and Thore, 1981; 
Seitz, 1981 
continued ... .. f 
Q) 
Immunoassay 
Type 
Fluorescence 
Immunoassay 
(FIA) 
Metallo immuno-
assay 
Sol-Particle 
Immunoassay 
(SPIA) 
Particle 
Counting 
Immunoassay 
Label(s) 
fluorophores 
metal atoms 
metal sols 
(i) latexes 
(ii) particles 
Table 1.2 continued 
Detection 
Method 
fluorimetry 
(i) colorimetry-
(ii) fluorimetry 
(i) visible 
response 
(i) visible 
reponse 
(ii) photometry 
Comments 
simple labelling; 
homogeneous 
methods possible; 
background effects 
possible 
See discussion in 
Section 1.2 
See discussion 
in Section 1.2 
may be difficult 
to obtain viability 
of label 
Reviews and Examples 
Q'Donnell and Suffin, 
1979; Soini and Hemmila, 
1979; Maggio, 1980; 
Quatrone et. al., 1981; 
Smith et. al.; 1981 (a) 
and (b); Ullman, 1979; 
1981; Van der Plas et. 
al., 1981; Visor and 
Schulman, 1981; Hicks, 
1984 
Cais, 1977; 
Cais, 1980; 
Wilmott et. al., 1984 
Leuvering et. al., 1980 
Cambiasio et. al., 1977 
continued ..... / 
Table 1.2 continued 
Immunoassay Label (s) Detection Comments Reviews and Examples Type Method 
Viroimmunoassay (i) Virus Bacterial culture complicated method; Haimovich and Sela, 1966 ; 
(ii) Bacterio- difficult to retain Makela, 1966 
phage viability of label 
Free Radical free radicals E.S.R. complex labelling; Leute et. al. J 1972 
complex instrument-
Immunoassay ation 
Voltammetric (i) isoenzyme voltametry experimental ·Yuan et. al. , 1981; 
electrodes methods may be quite Matthew et al., 1982 
Immunoassay (ii) metal complicated 
chelates 
(VIA) 
in certain cases these methods have effectively 
replaced RIA. Homogeneous enzyme immunoassays have also 
been developed, for example the Emit~ homogeneous assay 
for proteins of Rubenstein (1981). Enzyme immunoassay 
could perhaps be considered the most promising 
alternative to RIA, however, it does still have some 
disadvantages 
instabili ty of 
production. 
in terms 
labels and 
of lack of 
the cost 
sensitivity 
of enzyme 
Another area of non-isotopic immunoassa'y into 
which a considerable research effort has been directed 
in recent years is the 
specifically fluorescent 
use of luminescent labels, 
labels in fluorescence 
immunoassay (FIA) and chemiluminescent labels in 
chemiluminescence immunoassay (CLIA). 
FIA in principle needs only simple equipment and 
with pg ml -1 detection limits in pure solution has the 
potential sensitivity required of an alternative label; 
however, background interferences associated with serum 
samples have caused problems. These effects include 
native fluorescence of the sample (chiefly associated 
with the fluorescent bands of the proteins and protein 
bound materials such as bilirubin), scattering, high 
sample absorbance and quenching or enhancement effects. 
Attempts to overcome these problems have included 
careful choice of label, sample matrix preparation and 
chemical treatments both of the labels and within the 
method itself, but perhaps 
development has been 
the greatest success in 
achieved with the use 
FIA 
of 
spectroscopic techniques. Table 1.3 reviews techniques 
used in FIA. 
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Table 1.3 
A review of fluorescent techniques used in immunoassay 
Spectroscopic 
Technique 
Quenching and 
Enhancement FIA 
Fluorescence 
Polarisation 
(polarisation FIA) 
Energy Transfer 
Fluorescence 
Protection 
General 
Comments 
Reviews and 
Examples 
homogeneous assays, Shaw et.al., 
possible background 1977 
serum (urine) 
interference 
Smith, 1977 
Handley, 1977 
Lim, 1980 
homogeneous assays, Dandliker 
rapid and precise et.al., 1973, 
specialised 1980 
equipment 
sensitivity often 
low 
homogeneous assays, Ullman, 1976 
two labelling Ullman and 
procedures is a 
disadvantage 
Khanna, 1981 
homogeneous assays, Zuk et.al., 
two antibodies 1979, 1980 
required 
Fluorescence serum background Wel tman et. al. 
1973 Lifetime overcome 
(time resolved FIA) (Chapter3) 
Fluorescence many practical 
Internal Reflectance disadvantages 
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Lux and 
Dominique, 
1981 
Cais, 1980 
Kronick and 
Little, 1975 
Although many fluorescence immunoassays have 
been successfully developed in the research 
environment, they have met with limited commercial 
success due to the problems associated with complicated 
heterogeneous methods. The use of fluorescence 
lifetimes (time resolved PIA) appears to have potential 
because of the ability to overcome background effects 
and this is discussed in Chapter 3. 
The use of chemiluminescence in immunoassay 
offers the potential of low limits of detection using 
photon counting, requires simple apparatus and has the 
associated advantages of easy labelling of the antigen 
or antibody with a substance active in chemiluminescent 
reactions, (e.g., luminol, isoluminol and pyrogallol), 
i.e., following the immunoassay procedure the amount 
of labelled component is measured by a chemiluminescent 
reaction. 
Problems associated with CLIA such as background 
intaference, quenching and enhancement are not well 
documented but appear to pose some problems, as does 
the speed with which chemiluminescence reactions occur. 
The lifetimes of chemiluminescent reactions are such 
that CLIA on a large scale is difficult; however, with 
the introduction of the technique of flow injection 
analysis, where analysis may be carried out in a 
continuously flowing stream, these problems may be 
overcome, (Worsfold and Hughes, 1984). 
Of the other methods of non-isotopic immunoassay 
reviewed in Table 1.2 with the exception of those 
procedures using metal ions as labels, i. e., MIA and 
SPIA, which are discussed in Section 1.3 the methods 
involved are generally complicated, lack sensitivity or 
require expensive equipment and reagents. However, a 
method that does show some promise although still in 
the earlier stages of development is that of particle 
counting immunoassay (PCIA), (Cambiasio et.al., 1977). 
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1.2 METAL IONS AS LABELS IN IMMUNOASSAY 
1.2.1 General 
In principle metal ions might make exceptionally 
good labels in immunoassay, as suitably chosen ones 
would be inexpensive, stable, safe and detectable at 
the concentrations 
addition, in certain 
required in 
circumstances 
immunoassay. In 
some of their 
properties may be environment-sensitive leading to the 
development of homogeneous immunoassays. 
The use of metal ions as labels in immunoassay 
offers the potential of a wide range of detection 
methods such as emission, absorption and fluorescence 
spectrometry, anodicstripping voltammetry and other 
electrochemical methods, neutron activation analysis 
and spectrochemical analysis using inductively coupled 
plasma sources. Of 
spectrometry and 
these methods atomic absorption 
more specifically the method of 
electrothermal atomisation, is perhaps the most 
attractive. This method has the advantage of great 
sensitivity with a small sample volume while a 
carefully chosen operating programme will reduce 
background interferences almost to zero (see Chapter 
5). Fluorescence spectrometry using time resolved 
measurements (Chapter 3) also offers potential for 
routine analysis. The other methods mentioned have not 
been investigated during this project; however, several 
may offer advantages and warrant further study. 
Especially interesting are plasma emission spectrometry 
and neutron activation analysis where several metals 
may be determined simultaneously on each sample. 
To date, the development of immunoassays using 
metal ions as labels has been approached in two 
distinct ways: Cais and his co-workers have introduced 
a method termed Metalloimmunoassay (MIA) in which metal 
ions have either been introduced into the molecule of 
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the antigen (Cais, 1979) or.metal containing reagents 
have been covalently bonded to a functionalised hapten 
(Cais, 1977, 1980). (see discussion in Section 1.2.2). 
The alternative approach has been that of Leuvering 
et al., who have used colloidal metal particles as 
labels (Leuvering et al., 1980) (see discussion in 
Section 1.2.3). 
1,2.2 Metalloimmunoassay 
In their first paper on MIA Cais and his 
co-workers (Cais, 1977) suggested metal atoms, in the 
form of organometallic or co-ordination complexes, as 
labels for haptens or macromolecular antigens. Examples 
of metallohaptens prepared from the carboxylic acid and 
amino derivatives of the oestrogen steroids, and of 
barbiturate and cannabinoid metallohaptens are shown in 
Fig. 1.2. 
Antibodies were raised in rabbits using bovine 
serum albumin conjugates of the labelled haptens. 
Purified antibodies were then immobilised, for future 
use, by reaction with Sepharose 4B (Pharmacia). 
Analysis of the metallohaptens was carried out 
using atomic absorption spectrometry with 
electrothermal atomisation, satisfactory calibration 
curves in the metal concentration range 2-50 ng ml- 1 
being observed. This level corresponds to an unlabelled 
hapten concentration of the order of 20-500 ng ml-l , 
since the metal content is on average about 10 - 20% of 
the metallohapten. At this level certain urinary 
e.g., oestriol 
barbiturates and 
(in pregnancy 
amphetamines 
serum), 
may be 
metabolites 
morphine, 
determined 
concentration. 
without previous extraction and 
An example of the results obtained by Cais 
et.al., is illustrated using an oestradiol - 17 - e-
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Hapten Metallohapten 
CO(CH,.I2 COOH 
[OICH,i.CONHCH -<§J Fe @ 
HO [:60ICH,i,CONH -o{ol 
NH~ 
HO NHCO~ 
lD ~ 
OC c'o 'co 
Figure 1. 2 
Metallohaptens developed by Cais et.al. 
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o 
OH 
OOH 
Et Et OY'Y0 
HNyNH 
o 
OH 
<£,HCH,---@ Fe@ 
o Et Et yyo 
HNyN - S02-
o ~ 
OC'I 'CO 
CO 
. continued Figure 1 2 
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succinate rnetallohapten (I): 
HO 
Figure 1. 3 
I Oestradiol - 178 - succinate metallohapten 
Standard solutions of the rnetallohapten in O.OlM 
phosphate buffer (pH 7.3) were analysed in the 
concentration range 0 - 50 ng ml- 1 Fe, and the atomic 
absorption calibration curve was shown to have a 
correlation coefficient of 0.9977. 
Use of the inetallohapten (I) in an antibody 
titration with a Sepharose bound anti-oestradiol- 178 -
hemisuccinate antibody showed antibody-metallohapten 
binding. Using unlabelled steroid it was found that in 
the hapten concentration range 0.1 - 1 ~g ml- 1 a molar 
ra tic of unlabelled steroid to metallohapten of 1: 31 
was required to obtain 44% inhibition of metallohapten 
binding. 
From these results it can be seen that this type 
of approach has some potential, although the limits of 
detection of the compounds does not compare too 
favourably wiht the pg levels associated with RIA. 
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An alternative approach to MIA that has been 
attempted by this group is the direct introduction of 
the metal atom into the antigen molecule, e.g., the 
mercuration of the steroid oestrogens (Cais, 1979). 
Sulphonated cymantrene derivatives have also 
The methods of been used by Cais and his co-workers. 
synthesis of such functionalised sulphocymantrene 
in Figs. 1.5 and 1.6 derivatives (Cais, 1980) are given 
while specific examples of the labelling of 
phenobarbitone haptens are given in Figs. 1.7 and 1.8. 
Analysis of this type of metallohapten by atomic 
absorption spectrometry with electrothermal atomisation 
was demonsbated using manganese labelled phenobarbitone 
( II) ( Fig. 1. 4 ) • 
, 
,I .', 
I , , 
~' n', I ~o c -f-o- --:.CO " .".' 
, " 
"0 
o 
Figure 1. 4 
(11) Manganese - labelled phenobarbitone 
o 
A calibration curve in the concentration range 0 
-50 ppb Mn obtained with the manganese - labelled 
barbiturate metallohapten (11) in buffered solutions 
containing immunoassay concentrations of 
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co 
j 
1 
-S02(CH2)2NHCbz 
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tetrabutylammonium . sal t 
Synthesis of a carboxylic functionalised sulphonated 
cymantrene derivative 
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Et 
~ 0 
H 
Y 
o 
phenobarbitone 
(5-ethyl-5-phenyl 
barbituric acid) 
N-carboxymethyl 
derivative 
activated ester 
reaction with amine derivative 
of sulphonated cymantrene 
(Fig. 1.5) 
preparation of 
I I \ 
I I \ 
I I , \ 
o I~~..: ~CO 
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Figure 1. 7 
a manganese-labelled 
phenobarbitone derivative 1 
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derivative 
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N-ethyl ami no 
derivative 
co 
Preparation of a manganese-labelled 
derivative 2 
phenobarbitone 
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anti-phenobarbitone antisera gave a least squares 
linear regression equation of y = 4.92x - 0;03 (where y 
is the atomic absorption signal in mm and x the 
concentration of manganese in ppb) and a correlation 
coefficient of 0.995. In immunoassay terms these labels 
are relatively insensitive, no doubt partly because the 
metals used (Fe, Mn etc.) occur at high concentrations 
in biological samples. However, suitably chosen 
metal-containing reagents might make exceptionally 
sensitive labels (see Chapter 3). 
1.2.3 Sol Particle Immunoassay 
In their paper on the use of metal ions as 
labels in immunoassay Leuvering et al. (1980) described 
the use of colloidal metal particles as labels. The 
basic approach is to coat antibodies (to the antigen of 
interest) with colloidal metal particles and 
subsequently use these in a competition reaction for 
antigen, with unlabelled antibody. Detection of the 
bound or unbound fraction is carried out by 
colorimetry or atomic absorption spectroscopy with 
electrothermal atomisation. 
Leuvering discussed the determination of HPL and 
the simultaneous determination of HPL and HCG: 
(i) Sandwich SPIA for HPL 
In this assay colloidal gold (average particle 
diameter 60nm) was adsorbed onto the surface of 
anti-HPL. The conjugate was subsequently used in a 
sandwich immunoassay procedure using microtitration 
plates 'coated wi th anti-HPL. Determination of the bound 
fraction was carried out either visually, 
color:rmetrically': or by atomic absorption spectroscopy 
with electrothermal atomisation. Results of the SPIA 
and comparison of this method with other more 
established methods are given in Table 1.4. 
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Table 1.4 
Comparison of detection limits for immunoassay of HPL 
Assay type Detection method 
SPIA naked eye 
SPIA color.imeter 
SPIA CFAAS 
EIA naked eye 
EIA colorimeter 
RIA Y - counter 
RIA Y - counter 
Detection 1 imi t 
p mol r 1 
170.0 
5.4 
1.4 
110.0 
90.0 
6.5 
1.4 
As can be seen from Table 1.4 this method of 
SPIA compares favourably in terms of detection limits 
with both EIA and RIA. 
(ii) Simultaneous sandwich SPIA for HPL and HCG. 
The procedure as used in the assay of HPL was 
carried out, with silver particle anti-HPL conjugate 
and gold particle anti-HCG conjugate in equal volumes 
replacing the single conjugate of the previous 
experiment. Determination of the silver and gold 
contents of the bound fraction was carried out 
sequentially. 
Detection limits obtained in this simultaneous 
assay for HPL and HCG were 3 fmol 1-1 and 7 rmol 1-1 
respectively. 
From the results obtained by Leuvering et.al., 
it can be seen that the detection limits for SPIA 
compare· 
obviously 
favourably with RIA. Another advantage is 
the hazard free label which may in freeze 
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dried form be stored for a period of several months, 
although detection at the lower levels incurs the high 
costs associated with atomic absorption spectrometry 
with electrothermal_atomisation. 
In terms of an assay using metal ions as labels 
SPIA offers several advantages over the MIA procedures 
of Cais et.al. (Section 1.2.2), especially noticeable 
is the limit of detection, as in the system of Cais one 
metal atom (or a number <10) is bound per complex 
compared to the millions of atoms in every sol 
particle. Other features which favour SPIA include the 
physical method of adsorption for labelling the 
antibodies which will tend not to affect the antigenic 
character of the antibody as other methods do, the 
possibility of producing labelled conjugates with a 
long shelf life and the possibility of multicomponent 
analysis. The latter is especiallY attractive when 
considering the use of inductively coupled plasma 
> 
spectrometers or X-ray fluorescence. methods where 
simultaneous determination of all the metal labels can 
be made. 
In the light of the obvious advantages of SPIA 
as demonstrated by Leuvering, experimental work on this 
type of assay has been carried out and is discussed in 
Chapter 5. 
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CHAPTER TWO 
ELECTRONIC ENERGY TRANSFER 
2.1 ELECTRONIC EXCITATION 
Electronic excitation is most conveniently 
achieved by absorption of electromagnetic radiation. 
Absorption of light of an appropriate frequency by a 
molecule will promote an electron from a low energy 
occupied orbital to a higher energy previously 
unoccupied orbital; the wavelength of radiation 
associated with such a transition may be calculated 
from equation 2.1: 
). = hc 
Ex-Eo 
where). is the wavelength (m), h 
(J s), c is the velocity of 
energy gap between the ground and 
(2.1) 
is Planck' s constant 
• _1 
l~ght (m s ), Ex the 
excited states (J) 
and Eo the ground state energy (J). 
Radiation is generally absorbed in accordance 
with the laws of Beer and Lambert which state that the 
amount of radiation absorbed is proportional to the 
number of molecules absorbing the radiation and that 
the fraction of incident light absorbed by a medium is 
independent of the intensity of radiation, i.e., each 
succe~ve layer absorbs an equal fraction of the 
incident radiation. The laws are combined to give the 
Beer-Lambert law expressed by equation 2.2: 
log 10 Cl cl 
It 
( 2 • 2) 
where 10 is the incident radiation, It the transmitted 
radiation, c the concentration of the absorbing species 
and 1 the thickness of the absorbing medium. 
The absorbarice (A) , the quantity measured 
experimentally, is related to absorption and is defined 
by equation 2.3: 
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log 10 = A 
It 
= Ecl ( 2.3) 
The proportionality constant E, referred to as 
the molar 
degree of 
. abso~ptivity) 
allowedness of a 
is a measure of the 
transition. Transitions 
between electronic states are 'governed'.. by selection 
rules and result in transitions being referred to as 
allowed or forbidden. These terms, however, are 
relative and an estimate of the degree of allowedness 
of a transition may be made from the value of Emax of 
an absorption band. A forbidden transition has a 
maximum .'. abscirptivi t.i· E max < 10, a partially 
allowed transition has a value of Emax 10 - 1,000, an 
allowed transition a value of E max 1,000 - 10,000 and a 
value of E max > 10,000 refers to a fully allowed 
transition, all values of E have units of 1 mol-l cm-l 
From equations 2.3 and 2.4: 
10 = It + I (A) + I (REF) (2.4) 
where 10 and It are as before, I (A) is the radiation 
absorbed and I (REF) is the radiation reflected; 
assuming I (REF) to be 'negligible, the radiation 
absorbed by a system may be calculated from equation 
2.5: 
I (A) ( 2.5 ) 
Excitation results in the promotion of an 
electron to a vacant orbital as shown in Fig. 2.1: 
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E* --
E Jl 
1k H 
So SI 
Figure 
1 ~
Tl 
2.1 
Vacant orbita 15 
prior to 
excitation 
Occupied 
bonding 
orbi ta 15 
Energy level diagram showing the process of excitation 
Electronically excited singlet (51) or triplet 
(TU states are theoretically possible. 5 inglet states 
are where the excited electron remains paired in an 
antiparallel fashion to the electron in E, with no 
resultant spin magnetic moment. Triplet states are 
where the excited electron spin is unpaired and 
parallel to the electron remaining in E; the triplet 
state does possess a net spin magnetic moment. Most 
excited states are initially found in the singlet state 
as transitions between states of unlike multiplicity 
(process hv2) are spin forbidden. However, triplet 
states are still formed by intramolecular intersystem 
crossing processes (ISC) which results in the electron 
becoming inverted. 
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2.2 DEACTIVATION OF EXCITED STATES 
Sr 
So 
b 
~ . 
.. 
t 3 ~ ... 
>. , 3 
en 0 2-
'-QJ 
c:: 
Lo.J 
~ 
'" .~ ...,
c:: 
QJ 
..., 
0 hv F le Q. 
Internuclear distance + 
Figure 2.2 
Deactivation of excited states 
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Most of the major photophysical processes are 
shown in Fig. 2.2. Absorption of a photon populates an 
upper singlet state forming an excited molecule. The 
excess energy of the excited molecule may be lost in a 
number of ways. Most co~nly the molecule will relieve 
itself of the excess energy by the rapid cascade 
(10-12·10-13 s) to the lowest vibrational energy level, J 
= 0, of Sl. From this state the energy may be lost 
either as emission, fluorescence, or by the 
radiationless process, internal conversion (IC) which 
involves vibronic coupling to a vibrational level of SO 
followed again by a rapid return to a low vibrational 
level. The process where the excess energy of the 
molecule is not lost as light results in conversion to 
heat which is lost to the surroundings. The lifetime of 
the lowest singlet excited state is generally between 
10 -6 to 10 -9 seconds and the radiative and 
non-radiative processes to deactivate this state are in 
direct competition with each other. 
There are two radiative processes shown in Fig. 
2.2: fluorescence between states of the same spin type, 
e.g., Sl~ SO, and phosphorescence between states of 
different spin types, e.g., Tl-.SO. Excited triplet 
states are not formed in any significant quantity by a 
direct absorption process, the SO ~ TX transition being 
of the order of 10-6 of the transition to an excited 
singlet state (SO~SX) but the triplet state may still 
be formed by the process of intersystem crossing. 
The process of intersystem crossing occurs as a 
result of coupling between the singlet and triplet 
states. When the excited singlet state reaches J=2 in 
. Fig. 2.2, the potential energy surfaces of the singlet 
and triplet states cross, position C. Here both excited 
states posses the same potential energy and have 
identical nuclear configurations which results, during 
a vibration, in the molecule spending some of its time 
in the energy level J=2 of the state Sl and some of its 
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time in the isoenergetic 
establishing 
level J=4 of the triplet 
state, thus 
states, however, 
corresponding singlet 
an 
are of 
state 
equilibr ium. 
lower 
(Hund's 
energy 
rule) 
Triplet 
than the 
and thus 
internal conversion, i.e., the rapid cascade from J=4 
to J=O in the triplet level results in triplet state 
formation. 
The deactivation of Tl to SO can occur via the 
radiative spin forbidden phosphorescence process or by 
intersystem crossing to an upper vibrational level of 
51. Deactivation will generally proceed through the 
triplet state unless the thermal energy is large enough 
to allow the back reaction, i.e., intersystem crossing 
back to the singlet state, to occur. The triplet state 
generally has a lifetime between 10- 5 and 10 seconds, 
reflecting the forbidden nature of this transition. All 
the unimolecular processes depicted in Fig. 2.2 compete 
to deactivate excited state molecules, but there are 
also bimolecular processes capable of deactivating 
electronically excited states. 
Molecules known as donor molecules may transfer 
their energy to other molecules which results in the 
excitation of these acceptor molecules. This process 
can occur in both singlet and triplet states, and may 
generally be represented as below where an asterisk 
indicates an electronically excited state. 
D* + A ~ A* + D 
The donor process is of particular intere~t in 
rare earth chelates where intramolecular energy 
transfer occurs, energy being transferred from the 
excited chelating molecule to the rare earth chelate 
ion, which subsequently emits the energy as an 
emission. The process is discussed in Section 2.3 and 
its application in immunoassay in Chapter 3. 
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2.3 INTRAMOLECULAR ENERGY TRANSFER IN RARE EARTH 
CHELATES 
Intramolecular energy transfer (IMET) in rare 
earth chelates under excitation by near ultra violet 
light was first reported by Weissman (1942). Using 
europium chelates he found that excitation of the metal 
complex in the region of light absorption associated 
primarily with the ligands of the complex resulted in a 
high yield of "line like" atomic emission 
characteristic of the metal ion. It was also shown by 
Weissman that direct excitation of the 4f energy levels 
of the metal ions was not responsible for the emission, 
but an intramolecular energy transfer from the 
electronic states associated with the ligand to 
localised intra-4f shell energy levels of the ions was 
involved. 
2.3.1 The requirement for energy transfer 
Using various rare earth chelates at a 
concentration approximately 10 -5 M in ether: 3-
methylpentane: absolute ethanol (5:5:2 v/v) at liquid 
nitrogen temperature crosby et al., (1961) measured 
triplet state energies by phosphoresence assuming a O~ 
o transition, in complexes where band emission 
predominated over line 
(emitting) energy levels of 
emiss.ion. The resonance 
to these 
energies 
, 
the ions were then compared 
triplet state experimentally determined 
to yield the following 
lowest 
requirement for line 
emission from a given chelate: Tor IMET to occur the 
lowest triplet state energy level of the complex must 
be nearly equal to or must lie above the resonance 
energy of the rare earth ion. 
The above requirement for IMET is best 
demonstrated by europium which fluoresces strongly from 
two well established resonance levels (Sayre and Freed, 
1956), at 17,250 cm-l and 19,020 cm-I, line emission 
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only being seen from the lower level at 17,250 cm- 1 in 
the 8-hydroxyquinolate chelates whose triplet states 
lie between the two resonance levels whilst chelates 
with triplet states above the upper resonance level 
show emission from both levels (Fig 2.3). 
~ Resonance levels of Eu 
22 MB3 benzoylacetonate complex I~B3 
tribenzoylmethide complex 
20 r~T 3 MT3 2-methyl-8-hydroxy-M(2Me8HQ)3 
---
quinolate 
18 M(2Me8HQ)3 M(8HQ)3 8-hydroxyquinolate complex 
M(8HQ)3 
16 
14 
Figure 2.3 
Resonance levels of europium and measured triplet state 
energies of complexes 
2.3.2 Luminescence efficiencies 
The luminescence efficiencies vary considerably 
between the rare earth ions (when the triplet state is 
above the reson~ce level of the chelated ion) which may 
suggest a difference in energy transfer ·efficiencies 
between the various ions. However·, as the lanthanide 
ions are chemically similar and it is likely that the 
4f shells are little affected by chelate formation due 
to effective ·shielding by the outer electrons Crosby 
(1961) postulated that energy transfer is similar in 
all cases, but that for efficient emission large energy 
,gaps must exist between the resonance levels and the 
lower excited states for the radiative processes to 
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.. 
compete 
postulate 
favourably with the non-radiative ones. This 
is substantiated by the high yield of 
luminescence observed for La 3+ and Gd 3+ chelates, which 
energy levels· and the have no low lying 4f 
corresponding low yield for the chelates of pr3+ and 
Nd 3+ which have numerous closely packed excited states 
in the ion. 
2.3.3 The mechanism of lMET 
Excitation of the central metal ion by direct 
transfer from the first excited singlet state (SI) is 
energetically possible; however, various reported 
experiments (Lyle et al., 1972; Mushrush, 1971) have 
shown this pathway to be unimportant. Presumably either 
because the 4f electronic levels do not couple with the 
vibronic levels of SI or transfer processes dependant 
upon such coupling are not competitive with other 
processes depopulating the state, i.e., vibrational 
internal conversion, fluorescence and intersystem 
crossing to the triplet state. Using a study of 
europium diketonates Lyle et.al. (1972) postulated the 
mechanism shown in Fig. 2.4: 
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hv 
Energy levels of the ligand 
Figure 2.4 
Resonance 
level 
1 . .. I lne emlSSlon 
Ground 
; 
state 
Energy levels of the metal ion 
The mechanism for IMET by vibrational coupling of the 
4f excited state of the ion to a triplet manifiold of 
the ligand. 
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Once intersystem crossing has occuued, radiative 
decay is spin forbidden and thus much slower, hence the 
non-radiative IMET process becomes competitive making 
the above mechanism 'feasible. 
,Mushrush (1971) suggested, as 
experimental observations, that the 
occurs Crosby 
a result of 
energy transfer 
et al. <1962, 
1963) 
from the n,u* state (T2). 
have also demonstrated the above suggesting 
energy transfer from either an excited vibrational 
level of the triplet or a higher electronic level of 
the system. 
The possibilities for triplet state energies 
relative to the resonance energy level of the metal ion 
are represented in Fig. 2.5: 
>, 
Cl 
>-QJ 
co 
W 
Case A 
\ 
"- )-"" 
-
Casl! B Case C 
/ 
./ 
J 
Figure 2.5 
A schematic diagram of the potential energy surfaces of 
the triplet state (T) and the 4f level of the ion. 
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In case "A", the resonance level of the ion is 
below the zeroth vibrational level of the triplet 
state, hence transfer may occur from the zeroth 
vibrational level to some vibrational level of the 
metal ion. Case "B" represents the situation where 
transfer must occur from a higher vibronic level and 
case "CH the situation where the resonance level is 
slightly above the triplet level. Mushrush (1971) and 
Crosby's (1962 a,b; 1963) experimental evidence 
suggests that case ·"B" or "C" represents the true 
mechanism, as the lifetime of the line emission is 
somewhat shorter than the phosphores~ce lifetime, 
suggesting that transfer does not occur from the zeroth 
vibrational level as such transfers would have a 
lifetime equal to that of the phosphoresance, transfer 
occurring as long as the triplet state is populated. 
Bhaumik (1964) has also shown that transfer from 
the triplet state occurs to a higher level in the metal 
ion than the emitting level, a definite relaxation time 
being involved, e.g., approximately 2 ~sec. for 
europium dibenzoylmethide. The relaxation time, 
however, is much faster than the radiative decay time 
and consequently only weak lines are observed for this 
transition. 
Alternative interpretations to the vibrational 
coupling of the 4f excited states of the ion to some 
triplet manifold of the complex have been suggested: 
These include a charge transfer followed by a Forster 
type mechanism as proposed by Spooner (1959); this, 
however, seems doubtful because for this mechanism to 
operate, a significant red shift of the phosphorescence 
must occur which is not observed experimentally. The 
possibility of a purely F~rster type mechanism is also 
unlikely as the necessary condition of overlap of the 
emission of the complex and the absorption of the ion 
is not always fulfilled. 
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The effect of the ligand on fluorescence- intensity and 
lifetime: 
The intensity of the fluorescence observed for 
rare earth chelates is strongly dependent upon 
environment. In chelates with oxygen atoms as donors, 
energy transfer through a 
inferior to that of a 
it has been found that the 
bond is metal oxygen ionic 
covalent bond. This is also generally true for nitrogen 
atom donors, hence to obtain maximum fluorescence 
intensity, one should choose a chelate with a covalent 
type bonding. 
The nature of the ligand of which the donor is a 
part is also significant. Sinah et al. (1964), on 
comparison of europium phthalate complexes with europium 
naphthalate complexes, found an enhancement of 
fluorescence intensity of l5x on replacement of 
phthalatewith naphtha late;. The naphthalate,iinion through 
resonance is obviously a better donor in the IMET 
process probably due to the increased conjugation in 
the system. 
Sinah (1966) also studied the effect of dimethyl 
para-substution in dipyridyl chelates of europium and 
terbium. The intensity ratios - substituted / 
unsubstituted found experimentally were: 
Eu 5 n D2 7 + F;2 ~ 3.7 
n5 Do + 7 Fl ~ 1.4 
Tb n5 D4 + 7 Fl ~ 1.6 
(average value) 
These results suggest that the increased 
electron density around the nitrogen co~ordination site 
due to the electron releasing effect of the methyl 
groups leads to a better orbital overlap of the metal 
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ligand bond and hence increased fluorescence. The 
different values for the two transitions of Eu 
suggest a difference in transition probabilities for 
the two levels, again sensitive to environment. This 
effect is, however, not observed for Tb. 
By far the most work on the effects of 
substitution in the ligand portion of the complex has 
been carried out on diketone complexes. The following 
is a summary of the findings of Filipescue et al. 
(1964). 
The effect of electron donating groups: 
substitution of electron donating groups e.g., 
methoxy groups was found to enhance fluorescence as did 
substitution of methyl groups in dipyridyl complexes by 
Sinha (1966). 
The effect of electron withdrawing groups: 
Meta- and para- substitution of nitro groups in 
the e-diketone complexes results in a decrease in the 
fluorescence intensity. Mono- sUbstitution is much less 
efficient in reducing the energy as it increases the 
asymmetry of the complex which tends to promote ionic 
emission. oi- substitution, however, considerably 
decreases the fluorescence intensity. 
Aryl-alkyl substituted diketones: 
This type of complex shows large fluorescence 
intensities due to the asymmetry of the system. The 
need for the complex to cause the metal ion to donate 
from an environment of centrosyrnmetry where the 
intra-4f energy transitions are forbidden to an 
asymmetric situation where the transitions are allowed 
is well fulfilled in this case. 
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CF3 groups to replace methyl groups: 
The substitution of CF3 for CH3 may in some 
cases lower the triplet state energy to a position 
where it is well matched with the resonance energy of 
the metal ion and hence may be a useful tool in 
matching these energies. 
From the above it can be seen that a given 
ligand may be modified in order to give an increased 
fluorescence intensity; however, the most important 
factor in the IMET process remains the matching of 
triplet and resonance energy levels, the closer the 
correspondance the greater the energy transfer and 
hence the fluorescence intensity. 
Temperature and solvent also have significant 
effects upon the process. However, as the nature of 
future experiments require that aqueous solutions at 
room temperature are used these have not been 
considered. 
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CHAPTER THREE 
TERBIUM-TRANSFERRIN AS A POTENTIAL LABEL 
IN IMMUNOASSAY AND THE IMMUNOASSAY OF 
GENTAMICIN 
• 
3.1 MATERIALS AND GENERAL METHODS 
3.1.1 Materials 
Anti-rabbit IgG 
Buffer tablets 
l-ethyl-3-(3-dimethyl-
Sigma (London) Chemical Co. 
Ltd., Poole, Dorset.· 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
Sigma (London) Chemical Co. 
aminopropyl) carbodiimide Ltd., Poole, Dorset. 
hydrochloride 
Gentamicin sulphate 
Glycine 
Human serum transferrin 
(iron free) 
Hydrochloric acid, SLR 
125 1 - Gentamicin 
POlO Sephadex G25 
columns, 25ml 
Rabbit serum 
RIA Kit for Gentamicin 
Sigma (London) Chemical Co. 
Ltd., Poole, Dorset. 
Aldrich Chemical Co. 
Gillingham, Dorset. 
Sigma (London) Chemical Co. 
Ltd., Poole, Dor set. 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
RIA (U.K.) Ltd., Washington, 
Tyne and Wear. 
Pharmacia (Great Britain) 
Ltd., Milton Keynes. 
Sigma (London) Chemical Co. 
Ltd., Poole, Dorset. 
RIA (U. K.) Ltd., Washington, 
Tyne and Wear. 
Sephadex G25 Pharmacia (Great Britain) 
Ltd., Milton Keynes. 
Sodium hydrogen carbonate Fisons Scientific Apparatus, 
, 
Loughborough, Leics. 
Standard human serum The Boehringer Corporation 
(London) Ltd., Lewes, E. 
Sussex. 
Terbium (Ill) chloride 
hexahydrate (99%) 
"Tris buffer" 
Aldrich Chemical Co. 
Gillingham, Dorset. 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
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• 
·3.1.2 General methods 
Buffer preparation 
O.lM 2-amino-2-(hydroxymethyllpropane-l,3-diol 
(Trisl - hydrochloric acid - bicarbonate buffer was 
prepared as follows: 12.1g of Tris and 0.12g of sodium 
hydrogen carbonate were dissolved in 1 litre of triply 
distilled water which had been collected into glass. 
The pH of the buffer was then adjusted to pH 8.5 by the 
dropwise addition of concentrated hydrochloric acid. 
Separation of the protein fraction of a mixture using a 
PD10 Sephadex G2S column 
Before separation of the mixture the columns 
were equilibrated with Tris-HC1-bicarbonate buffer (see 
abovel by passing 25ml of the buffer through the 
column. Samples of 2.Sml volume were loaded onto the 
column and eluted with 3.5ml of buffer solution. 
The elution profile for the columns is given in 
Figure 3.1. 
t: 
o 
.~ 
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'" s-..,
t: 
Cl! 
U 
<:: 
o 
u 
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Pro ein 
F r ti on 
4 ·6 8 10 12 
Figure 3.1 Elution Volume (ml) 
The elution profile of a PD10 Sephadex G2S column 
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RIA for gentamicin - Standard procedure 
(i) Samples or standards (10 ~l) were pipetted into 
assay tubes. 
(ii) 200 ~ 1 of phosphate buffered saline was added to 
blank tubes. 
(iii) 200 ~l of 125 I-gentamicin labelled tracer was 
added to all the tubes, and the tubes shaken. 
( iv) 200 ~ 1 of gentamicin antibody was added to all 
tubes except the blanks, and the tubes shaken. 
(v) 200 ~l of second antibody was added to all tubes 
and the tubes shaken. The tubes were then incubated at 
37°C for 30 minutes. 
(vi) The tubes were shaken and centrifuged at 3000 rpm. 
for 15 minutes. 
(vii) The supernatant was decanted and the pellet· 
counted for 1 minute. 
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3.2 INSTRUMENTATION 
3.2.1 Absorbance measurements 
measurements of absorbances at 
Unicam 
fixed 
SP800 
The 
wavelengths 
spectrometer 
Uvikon 10 
were routinely made on a pye 
(pye Unicam Ltd., Cambridge) and a Kontron 
spectrometer (Kontron Analytical, St. 
Albans). continuous spectra were recorded using the 
Kontron spectrometer and an absorbance attachment for a 
Perkin Elmer LS5 luminescence spectrometer with Model 
3600 Data Station (Perkin Elmer Ltd., Beaconsfield, 
Bucks) . 
3.2.2 pH measurements 
The pH values of solutions used in the 
experimental work were measured on a pye Unicam pH 
meter fitted with a 'combined glass electrode. The 
instrument response was checked before use with buffer 
solutions made from pH 4.0, 7.0 or 9.0 buffer tablets. 
3.2.3 Fluorescence measurements 
All fluorescence spectra were measured on a 
Perkin Elmer LS5 luminescence spectrometer fitted with 
a R928 photomultiplier. Data was recorded using a 
I 
Perkin Elmer Model 3600 Data Station using PECLS 11 
applications software. 
The PECLS II software perrni tted the 
determination of fluorescence lifetimes, second 
derivative spectra and 3-dimensional emission and 
excitation spectra. 
All spectra were recorded using a temperature 
controlled lcm silica cell,' controlled at 37° C ± 1 C. 
All spectra were recorded uncorrected for the 
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wavelength dependence of the lamp output and 
photomultiplier response. 
Fluorescence measurements at fixed wavelengths 
were made by integrating the signal obtained over a 
period of seven seconds. 
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3.3 A TERBIUM-TRANSFERRIN COMPLEX AS A LABEL FOR 
IMMUNOASSAY 
3.3.1 The metal binding properties of transferrin 
Human transferrin is a glycoprotein (mwt. 
80,000) in the form of a single polypeptide chain. Its 
function in the body is to transport iron in the· form 
of ferric ions. Transferrin binds two ferric ions per 
molecule, binding increasing above pH 7.0 and complete 
dissociation occurring at approximately pH 4.5. 
The binding of each ferric ion by transferrin 
results in the displacement of three hydrogen ions from 
the protein and the simultaneous binding of one 
bicarbonate ion. 
Generally: 
+ 
+ 3H 
Two histidine and three tyrosine residues are 
believed to participate in the metal binding site, 2-4 
nitrogen ligands, two of which involve the imidazole 
rings of the amino acids are thought to be formed in 
each case (Jacobs and Worwood, 1974). 
Iron has a much greater affinity for transferrin 
, 
than other metal ions. tlowever, in the absence of iron, 
metal ions with similar ionic size are able to occupy 
the iron binding site. In the case of the lanthanide 
terbium binding to transferrin a fluorescent complex is 
formed, the fluorescence of which is associated with an 
intramolecular energy transfer from the lowest triplet 
state of the transferrin to the lanthanide ion (see 
Chapter 2). 
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3.3.2 Formation of thekerbium - transferrin complex 
The complex of terbium with transferrin was 
prepared in O.lM Tris hydrochloric acid buffer 
containing 5 x 10-3 M sodium bicarbonate (Luk, 1971). 
Iron-free transferrin (10- 5 M) was prepared in the 
buffer solution and to this 2 x 10-4M aqueous Tb 
added in the molar ratio transferrin terbium 1: 2. 
Complex formation was achieved by simple mixing. 
3.3.3 Investigation of the fluorescence properties of 
the complex 
The excitation and emission maxima were 
determined using the "pre-scan" function of the LS5 
spectrometer. The maxima were found to 
excitation and 548nm for emission 
be 
(Fig. 
295nm for 
3.2) when 
working in the fluorescence mode. Slit widths of 5.0nm 
were used. 
The spectrum obtained for the terbium 
transferrin complex was subsequently compared with that 
of aqueous terbium chloride solution (Fig. 3.3). It can 
be seen that on complex formation the fluorescence 
intensity is enhanced by a factor of 10 5 over that of 
terbium chloride in aqueous solution when excited at 
295nm. However, no enhancement was observed with 
excitation at 352nm, the excitation maximum for the 
terbium chloride solution, as is shown in the 3 
dimensional plot of excitation, Fig. 3.4. This may be 
attributed to the fact that the absorption corresponds 
to the absorption characteristics of the transferrin 
molecule (F ig. 3.5) , wh ich absorbs energy and 
subsequently donates it in an intramolecular energy 
transfer process (see Chapter 2). 
Lifetime studies of the complex were made using 
the Perkin Elmer programme DECAY. The lifetime of the 
complex was determined to be 1.25ms compared to a value 
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of 0.43ms for aqueous terbium chloride solution. 
The limit of detection of 
respect to transferrin was determined 
the complex 
-7 
as 10 M. 
with 
Experiments to determine the rate of formation 
and stability of the complex as a function of 
fluorescence intensity at 548nrn were carried out and 
the resultsrueshown in Table 3.1. Complex formation was 
found to be complete one hour after mixing and the 
complex stable over a period of at least six days. 
Table 3.1 
Results for the rate of formation and stability of the 
terbium - transferrin complex 
Time After Complex Fluorescence Intensity 
Formation at 548nrn 
Immediately 27.5 
5 minutes 71.5 
10 minutes 87.1 
30 minutes 97.5 
1 hour 97.3 
2 hours 98.2 
5 hours 97.1 
24 hours 98.6 
48 hours 98.8 
1 week 96.2 
3.3.4 Investigation of the shape of the terbium 
transferrin complex 
The split peak at 490nrn and unsyrnrnetrical peak 
at 548nrn (Fig. 3.2) suggests that the two binding sites 
on the transferrin molecule may not be identical. First 
and second derivative spectra of the complex were 
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prepared and are shown in Fig. 3..6. As can be seen from 
the second derivative spectrum the sites cannot be 
totally resolved, suggesting that they do share some 
similar characteristics. 
3.3.5 A study of the effect of human serum on the 
fluorescence of the terbium - transferrin complex 
Fig. 3.7 shows the spectrum of a 1 100 
dilution of human serum in Tris - Hel - bicarbonate 
buffer pH 8.5, measured with an excitation wavelength 
of 295nm (maximum for the complex) over the emission 
range of the complex. Under these conditions a band of 
in~ference associated with second order scatter from 
the proteins of the serum is observed at 585nm, a 
position where intuference with the maximum emission 
from the complex may occur. With a delay gate of 0.02 
ms (using the phosphorescence mode of operation of the 
spectrometer) the background int~erence was 
considerably reduced and at a delay time of 0.05 ms 
total removal of the background effects was achieved. 
The effect on the fluorescence of the complex when 
using a 0.05 ms delay gate was to reduce the intensity 
of fluorescence by less than 3%, due to the 
fluorescence lifetime of the complex. Having considered 
the operating conditions of the spectrometer, with a 
view to total removal of the background in~erences 
from human serum it was decided to use the following 
operating parameters in further studies of the terbium 
- transferrin complex: 
Phosphorescence mode with autozero 
Delay Time 
Gate Time 
Excitation wavelength 
Slits 
Emission Scan 
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A study of the effect of direct introduction of 
human serum to the terbium - transferrin complex was 
made by the addition of human serum to a concentration 
of 1 : 100 to a sample of the complex. Fluorescence 
measurements were then made on the solution over a 
period of five days and the reduction in intensity of 
fluorescence recorded (Table 3.2). 
Table 3.2 
The effect of human serum on the fluorescence of the 
terbium - transferrin complex 
Time after addition Percentage los~ 
Immediately 12 
1 hour 13 
24 hours 35 
5 days 70 
From the results in Table 3.2 it was concluded 
that although the fluorescence intensity of the terbium 
transferrin complex is reduced on the addition of 
human serum, the percentage reduction over the period 
of time required to carry out an immunoassay procedure, 
i.e. 1 to 2 hours, was such that the fluorescence 
intensity was sufficient for this type of procedure. 
The initial reduction of intensity may be 
attributed to the increased absorbance of the solution 
at 295 nm, i.e. an increase from 1.148 for the terbium 
- transferrin complex in buffer solution to 2.332 for 
in buffer containing serum. Further the complex 
reduction of the fluorescence over a period of days 
could no doubt be attributed to the replacement of 
terbium by metals with a greater affinity for the 
transferrin metal binding sites. 
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3.3.6 Linking of gentamicin to the terbium 
transferrin complex 
Gentamicin (Fig. 3.8) is a broad spectrum 
aminoglycosidic antibiotic used in the treatment of 
severe infections of gram-negative bacteria. Its major 
disadvantage is that it is both ototoxic and 
nephrotoxic in large doses, hence its concentration in 
be carefully monitored. The optimum serum must 
therapeutic concentration of gentamicin is 4 12 .mg 
1 -I in human serum , a level which is maintained by 
intra-muscular injection every eight hours. 
RI 
Cl H 
Cl Me 
C 2 Mc 
H 
R2 
NH2 
NH,2 
H 
I 
RI-C-R2 
OH 
H~ 
NH-Me 
o Fig. 3.8 
The Gentamici ns 
H2 
H 
The required levels of gentamicin are such that 
the terbium transferrin complex, which may be 
detected to a level of 10- 7 M in 1 100 human serum 
seems a suitable label for use in immunoassay. 
Linking of gentamicin to the complex was 
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achieved using a carbodiimide reaction (Goodfriend 
et al., 1964), a free acid group on the transferrin 
molecule being linked to a free amino group on the 
gentamicin molecule. The carbodiimide reagent used in 
the experiment was l-ethyl-3-(3-dimethyl-aminopropyl) 
carbodiimide hydrochloride. The general reaction scheme 
used is shown in Fig. 3.9. 
A 1.5 ml aqueous solution containing 10 mg 
transferrin and 20 mg gentamicin was added to 150 mg of 
freshly dissolved carbodiimide hydrochloride in 1 ml of 
water. The mixture was allowed to react at room 
temperature before termination of the reaction by 
separation of the protein fraction using a PD-IO 
Sephadex G25 column (pre-equilibrated with Tris - HCl -
bicarbonate buffer) by elution with buffer solution. 
Fluorescence intensities of the complexes prepared from 
gentamicin linked transferrin are given in Table 3.3. 
Table 3.3 
Fluorescence intensities of gentamicin linked terbium -
transferrin complexes 
Carbodiimide 
conditions 
Reference complex 
i.e., no gentamicin 
5 min. reaction 
45 min. reaction 
3 hour reaction 
Relative peak 
height 
116.8 
66.8 
25.9 
o 
with increased time of the carbodiimide reaction 
the resultant fluorescence intensity of the 
terbium transferrin complex formed 
gentamicin 
from the 
reaction product decreases no doubt due to the blocking 
of the metal binding sites on the transferrin molecule 
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11 
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Figure 3.9 
Cl 
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Free acid group 
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Cl 
The carbodiimide reaction scheme for linking gentamicin 
. to transferrin 
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by gentamicin molecules. 
verification of the gentamicin binding in the 
carbodiimide reaction was carried out using a sample of 
125 1- gentamicin. 
Analysis of the gentamicin linked transferrin 
for its gentamicin content was carried 
radioimmunoassay (RIA) (Section 3.1.2). 
out by 
On analysis of the carbodiimide reaction 
products for the reactions described previously it was 
found that in all cases the gentamicin concentration 
was greater than the upper limit of the assay range, 
i.e., greater than 32 ~g ml- 1 • Upon serial dilution it 
was found that 1 : 10 dilution also contained amounts 
of gentamicin outside the assay range while a 1 : 100 
dilution of the 5 minute reaction product contained 8 
ug ml -1 gentamicin and a 1 : 100 dilution of the 45 
minute reaction product 14 ~g ml- 1 • 
From these results it can be seen that in order 
to obtain a gentamicin linked terbium - transferrin 
complex with a suitable gentamicin content i.e., within 
the required assay range, dilution of the complex to 
10- 7 M w.r.t. transferrin would be necessary. At this 
level dilution has occurred to the limit of detection of 
the complex. It is, therefore, necessary to develop a 
method of linking a smaller number of gentamicin 
molecules per transferrin molecule. 
reduction of the amount of gentamicin 
added 
Simple 
to the reaction mixture would almost certainly 
result in cross- linking of the transferrin molecules. 
Hence it was decided that a molecule that would link to 
the transferrin molecule in place of some of the 
gentamicin molecules should be added to the reaction 
mixture. It was decided to choose glycine as the 
molecule to be attached as it was hoped that it would 
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not bind preferentially to amino or carboxylic acid 
groups on the transferrin molecule and hence not affect 
substantially the overall charge on the transferrin. 
The small size of the glycine was also thought to be an 
advantage in terms of steric effects. 
Having chosen to use glycine to replace some of 
the gentamicin molecules in the carbodiimide reaction 
to link gentamicin to transferrin carbodiimide, 
experiments were carried out as described previously, 
varying ratios of gentamicin and glycine replacing the 
20 mg of gentamicin. The results obtained for the 
gentamicin content of various reaction producs as 
determined by RIA are given in Table 3.4. 
Table 3.4 
Analysis results for the gentamicin content of 
gentamicin - glycine - transferrin products by RIA. 
Analyte C.P.S. Gentamicin 
determined/~g ml 
0 ~g ml standard 42039 
1 ~g ml standard 36557 
2 ~g ml standard 28737 
4 ~g ml standard 16771 
8 ~g ml standard 9860 
16 ~g ml standard 6481 
Glycine: Gentamicin 
0 20 1023 } 
2 18 540 } out of 
5 15 1703 } range 
10 10 1807 } 
15 : 5 7497 8-16 
18 2 11493 4- 8 
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From the results in Table 3.5 it can be seen 
that the glycine : gentamicin ratios with gentamicin 
contents useful for immunoassay, i.e., within the 0 to 
32 ~g ml assay range are 15 : 5 and 18 2. Using 
these results the following procedure for batch 
preparation of a glycine - gentamicin linked terbium 
transferrin complex was developed: 
30 mg of iron free transferrin, 56 mg of glycine 
and 4 mg of gentamicin in 1.5 ml of distilled water 
were added to 400 mg of carbodiimide, freshly dissolved 
in 1 ml of water. The mixture was then allowed to react 
for five minutes before separation on a PD10 column. 
The protein fraction was then diluted to 18 ml and 
terbium chloride solution added in a molar ratio 
transferrin to terbium 1 : 2. 
Assuming that all the gentamicin is bound to 
transferrin, this reaction represents the binding of 
the order of 10 gentamicin molecules per transferrin 
molecule. 
3.3.7 A study of the effect of the binding of 
gentamicin and glycine on the transferrin molecule 
In order to test for cross-linking of the 
transferrin molecules during the carbodiimide reaction 
process gel filtration experiments were carried out: A 
Sephadex G25 gel filtration column was prepared (50 cm 
column), the effluent from the column being fed through 
an HPLC UV detector, set at 280 nm to measure the 
protein eluted from the column. 
Samples of iron free transferrin and the 
transferrin linked to gentamicin and glycine by the 
carbodiimide reaction were applied to the column and 
eluted with Tris / HCl buffer. The elution profiles for 
the two samples were identical. It was, therefore, 
concluded that no cross-linking of the transferrin 
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molecules had occu~ed during the carbodiimide reaction 
process. 
The effect of the carbodiimide reaction process 
on the overall charge state of the transferrin molecule 
was investigated by electrophoresis on 
acetate. The electrophoretic mobility 
cellulose 
of the 
transferrin molecule was not significantly effected by 
the binding of gentamicin and glycine. 
3.3.8 The effect of binding glycine and gentamicin on 
the properties of the terbium - transferrin complex 
In terms of the fluorescence properti~s of the 
complex the addition of glycine and gentamicin had 
little effect: ~he excitation and emission maxima were 
not altered and the basic spectral shape of the 
emission spectrum was virtually unchanged, although a 
slight alteration of the split peak at 490nm was 
observed (Fig. 3.10). The fluorescence intensity of the 
complex linked to gentamicin and glycine was reduced by 
less than 5% when compared to that of the original 
complex. Lifetime studies showed that the binding had 
no effect upon the 1.25 ms lifetime of the terbium -
transferrin complex. 
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Table 3.5 shows results obtained for stability 
tests on the gentamicin - glycine bound complex. 
Table 3.5 
Results of stability tests on the glycine - gentamicin 
bound terbium - transferrin complex 
Time after 
formation 
0 min. 
5 min. 
10 min. 
15 min. 
30 min. 
45 min. 
1 hour 
24 hours 
7 days 
Fluorescence Fluorescence 
intensity in intensity in 
buffer 1 : 100 serum 
104.9 64.2 
109.5 67.4 
103.5 71. 2 
104.2 72.8 
107.1 74.1 
106.2 74.8 
107.0 77.4 
109.0 77.5 
10l. 9 77.4 
As can be seen from Table 3.5 the glycine -
gentamicin bound complex is stable in buffer and buffer 
containing 1 : 100 human serum over a period of at 
least seven days. 
Absorbance measurements at 295 rum showed that 
the decrease in fluorescence intensity in 1 : 100 serum 
was due to the increased absorbance of the solution at 
that wavelength. 
3. 3.9 Titration of the glycine ~entamicin 
transferrin - terbium complex against anti-gentamicin 
Experiments to test recognition of the 
gentamicin complex.by anti-gentamicin were carried out 
using the double antibody technique: 2 ml of the 
complex was added to 0.2 ml of varying dilutions of 
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anti-gentamicin (antiserum raised in 
incubated at room temperature for one 
the incubation anti-rabbit IgG (second 
rabbits) and 
hour. Following 
antibody) was 
added in order to precipitate the anti-gentamicin. 
Fluorescence measurements were then made following 
centrifugation to remove antibody bound complex. The 
results of the antibody titration are shown in Fig. 
3.11 and Table 3.6. 
Table 3.6 
Results for the titration of gentamicin - glycine bound 
complex against anti-gentamicin 
Dilution of anti-gentamicin Fluorescence intensity 
1 10 8.2 
1 100 27.1 
1 200 75.0 
1 500 155.4 
1 1000 186.1 
1 2000 192.6 
1 5000 199.7 
1 10 000 194.7 
no 1st antibody 231. 7 
no 2nd antibody 227.3 
Reference fluorescence intensity 232.1 
Fig. 3.11 shows that there is good antibody 
recognition of 
typical of such 
the complex, the curve 
a dilution analysis. 
shape being 
From the results obtained for the tubes 
containing only one antibody it can be seen that the 
removal of the fluorescent complex from solution is a 
result of binding' to first antibody and subsequent 
precipitation by second antibody. These results 
preclude the situation which may have occurred whereby 
cross-linking of the transferrin molecules by antibody 
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FIG. 3.11 TITRATION OF Tb TRANSFERRIN COMPLEX AGAINST ANTI-GENTAMICIN 
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Dilution of anti-gentamicin 
may have produced large lattices, which themselves 
would be removed from solution on account of their 
size. 
3.3.10 Development of an immunoassay procedure for 
gentamicin 
Initial experiments to develop an immunoassay 
procedure were carried out using the double antibody 
technique. The first antibody concentration was kept 
constant at a dilution of 1 : 500 (anti-gentamicin) 
with the second antibody matched by titre and standards 
were prepared in aqueous solution. The gentamicin 
standards were added to the complex along with the 
first antibody and the procedure as for the antibody 
titration repeated. 
Initial results shown in Fig. 3.12 and Table 3.7 
show that in principle the method is working, although 
some inbUference appears to be occwring affecting the 
results for the 32 ~gml standard. 
Table 3.7 
Preliminary results for the immunoassay of gentamicin 
Gentamicin / ~g ml 
o 
4 
8 
16 
32 
Fluorescence intensity 
63.0 
76.1 
96.9 
105.0 
88.3 
Reference fluorescence intensity 121.2 
Unfortunately, before it was possible to 
investigate the effects occur.ring at the 32 ~g ml 
gentamicin level it was necessary to obtain a new batch 
of antibodies. Using this new batch of antibodies 
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it was impossible to re-establish the competition 
reaction between the aqueous gentamicin standards and 
that in the complex, for the anti-gentamicin. 
Experiments were subsequently carried out on a 
wide range of antibody dilutions, even though the 
antibody titration results remained constant. Results 
using a 16 \.I g ml standard, chosen because it 
represented the half way point in the gentamicin assay 
range are shown in Table 3.8. Absorbance measurements 
were also recorded to check if the absorbance of the 
solutions was a factor affecting the fluorescence 
measurements. 
Results for the 
gentamicin and 
Antibody 
dilution 
1:10 
1:100 
1: 500 
1:1000 
1:10,000 
1:100,000 
l:lOG 
l:lOOG 
1:500G 
l:lOOOG 
l:lO,OOOG 
l:lOO,OOOG 
Table 3.8 
competition reaction between aqueous 
the gentamicin complex for 
anti-gentamicin 
Fluorescence 
intensity 
11. 0 
62.6 
92.3 
243.4 
247.2 
248.0 
13.2 
59.9 
89.3 
230.7 
230.1 
233.3 
lcm Abs 
295nm 
0.608 
0.609 
0.536 
0.597 
0.550 
0.561 
0.601 
0.596 
0.552 
0.557 
0.564 
0.552 
lcm Abs 
548nm 
0.071 
0.076 
0.066 
0.084 
0.082 
0.075 
0.066 
0.071 
0.059 
0.072 
0.061 
0.065 
G -16 \.Ig ml gentamicin standard added 
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As can be seen from Table 3.8 no competition was 
observed between the aqueous gentamicin standards and 
the gentamicin contained in the complex in all cases. 
Although the absorbance measurements recorded 
were virtually constant and, therefore, not expected to 
significantly atfect the fluorescence measurements 
their values were somewhat higher than ideal. 
Fluorescence measurements were, therefore, .carried out 
on 1 : 10 dilutions. The results obtained did not show 
any new trends only a reduction in fluorescence 
intensity associated with the dilution factor. 
In an alternative approach to this problem a 
procedure of pre-incubation of the 16 ~g m 1-' gentamicin 
standard with the anti-gentamicin prior to the addition 
of the complex was investigated. Pre-incubation times 
from 30 minutes to 24 hours were investigated 
(incubation on complex addition was for one hour as 
previous experiments had shown that reaction of the 
complex with anti-gentamicin was complete within one 
hour). Again-no competition reaction was observed. 
As no competition between gentamicin standards 
and the gentamicin complex for anti-gentamicin occurred 
it was decided to test if the binding of the gentamicin 
in the complex was specific or non-specific. A 
titration of the complex against rabbit serum was 
carried out using the double antibody technique, 
anti-rabbit IgG being used as the second antibody. 
Table 3.9 shows the results obtained for the dilution 
analysis. 
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Table 3.9 
Results for the titration of the gentamicin complex 
against rabbit serum 
Dilution of 
rabbit serum 
1:10 
1:50 
1:100 
1:500 
1:1000 
1:10 000 
Fluorescence intensity 
173.0 
175.3 
199.3 
200.4 
202.9 
202.7 
Reference fluorescence intensity 213.4 
As can be seen from Table 3.9 the reaction of 
the gentamicin complex with anti-gentamicin appears to 
be specific. 
Although it has been possible to show that the 
reaction of the complex with anti-gentamicin is 
specific (by virtue of the results for the titration of 
the complex against rabbit serum) and that removal of 
the anti-gentamicin bound complex from solution is a 
function of precipitation by second antibody and not 
cross-linking of the complex (Section 3.3.9) we were 
unable to produce a competitive binding assay in any of 
our experiments. 
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CHAPTER FOUR 
GENERAL COLLOID CHEMISTRY AND SPECIFIC 
ASPECTS RELATED TO COLLOIDAL GOLD 
4.1 GENERAL INTRODUCTION 
Definition: 
Colloidal systems may be defined as systems 
containing particles smaller that. III m. 
4.1.1 Classification of colloidal systems 
1. Colloidal dispersions: 
prepared from ground material, these systems are 
thermodynamically unstable due to their high surface 
free energy and are irreversible systems in the sense 
that they are not easily reconstituted after phase 
separation. 
2. True solutions of macromolecular material: 
(natural or synthetic) 
These systems are thermodynamically stable and 
reversible in the sense that they are easily 
reconstituted after separation of solute from solvent. 
3. Association colloids (colloidal electrolytes): 
Prepared by condensation from supersaturated 
solution these colloids are thermodynamically stable. 
4.1.2 Preparation of colloids 
Colloidal systems may be prepared in two ways: 
either degradation of bulk matter or aggregation of 
small molecules or ions. 
1. Degradation of bulk matter: 
Dispersion of bulk material by simple grinding 
in a mill does not generally lead to eKtensive 
subdivision owing to the tendency of smaller molecules 
to reunite under the influence of the mechanical forces 
or by virtue of the attractive forces between 
particles. 
Page 73 
After prolonged grinding an 
situation is reached. Finer dispersions may 
equilibrium 
be obtained 
by incorporating an inert diluent during grinding or by 
wet milling in the presence of surface active material. 
For example a sulphur sol in the upper colloidal 
size range may be prepared by grinding a mixture of 
sulphur and glucose, followed by recovery of the 
glucose by dispersion in water and dialysis. 
2. Aggregation of small molecules or ions: 
A high degree of dispersion is generally 
obtained when a sol is prepared by an aggregation 
method. Aggregation methods involve the formation of a 
molecularly dispersed supersaturated solution from 
which the material in question precipitates in a 
suitably divided form. A variety of methods may be 
used to cause precipitation including the substitution 
of a poor solvent for a good one, ultrasound and 
various chemical reactions. Colloids produced by 
aggregation methods are generally polydisperse 
(particles are present over a large size range). 
However, in certain cases for example, certain gold 
colloids, which will be discussed later, conditions may 
be controlled to produce a monodisperse sol. 
The. process 
methods: 
of colloid formation by aggregation 
This type of colloid formation involves two 
distinct stages prior to stabilisation of the colloid. 
These are nucleation and crystal growth. 
The relative rates of these two processes 
control the particle size of the colloid as can be seen 
from the following definitions: 
Nucleation this is the formation of centres of 
crystallisation. The initial rate of nucleation is 
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dependent upon the degree of supersaturation that can 
be reached before phase separation occurs. Hence 
colloidal solutions are most easily prepared when a 
substance has a low solubility. According to Volmer 
(1939) the rate of formation of nuclei (J) may be 
expressed in the following manner: 
J = K exp ( -k, ) 
(In C / Co)2 
where C is the concentration of the substance in the 
solution and Co the equilibrium concentration. 
In the case of highly soluble materials there is 
a tendency for the smaller particles formed on 
nucleation to redissolve and recrystallise on the 
larger particles with ageing of the colloid. 
crystal growth the rate of crystal growth is 
dependent upon several factors. These include the 
amount of material available, the viscosity, (which 
controls the rate of diffusion of material to the 
particle surface), the ease with which the material is 
correctly orientated into the crystal lattice, 
adsorption of impurities which act as growth inhibitors 
and particle-particle aggregation. 
4.1.3 purification of colloidal systems 
Colloidal solutions often contain certain 
soluble low molecular weight components, especially 
electrolytes which considerably reduce the stability of 
the colloid. Methods must, therefore, be used to 
separate out these components. The general principle of 
pur if ica tion 
difference 
impuri ties. 
include: 
is based upon the considerable size 
between the colloidal particles and 
Basic methods of colloid purification 
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1. Dialysis 
In this process, 
employed across which 
Experimentally the sol 
vessel the bottom of 
semi-permeable membrane, 
semi-permeable membranes are 
impurities may pass. 
to be purified is placed in a 
which consists of the 
and which is imersed in pure 
solvent. The process is somewhat slow. However, its 
rate may be increased by increasing the membrane size, 
increasing the pure solvent volume and by stirring. 
The choice of membrane is dependent upon the 
system concerned. However, collodion (a partially 
evaporated solution of cellulose nitrate in alcohol 
plus ether) or cellophane membranes are most comonly 
used in the case of aqueous solutions. 
Membranes with various, approximately known pore 
sizes are com~cially available. However, particle and 
pore sizes are difficult to correlate since membrane 
permeability is ·~fected by electrical repulsion when 
particle and membrane are of like charge and also by 
adsorption onto the membrane. 
2. Ultrafiltration 
This process involves the application of 
pressure or suction to force the solvent and small 
particles across a semi-permeable membrane, while 
larger particles are retained. The membrane is normally 
supported between fine wire screens or deposited on a 
highly porous support such as a sintered glass disc. 
3. Electrodialysis 
When the low molecular weight component is an 
electrolyte, dialysis can be accelerated by applying an 
electric field between auxilary electrodes in the 
solution on both sides of the membrane of choice. This 
m~thod is particularly useful for low electrolyte 
levels as in these cases dialysis is extremely slow due 
to the small concentration gradient across the 
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membrane. 
Since the membranes acquire an electric charge 
on contact with the liquid, electrodialysis can be 
associated with changes in the ionic composition of the 
colloidal solution, and its pH can undergo a 
corresponding change. These changes are caused by the 
fact that the electrically charged membranes have an 
unequal permeability with respect to cations and 
anions. To avoid this undesirable effect the membranes 
to be used in electrodialysis are treated with various 
substances with a view to reducing their own charge. 
The selective power of the membranes is used in 
some cases for a selective purification or for the 
acceleration of electrodialysis. In such a case, the 
anodic and cathodic membranes are prepared from 
materials which acquire opposite signs on contact with 
the solution. 
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4.2 PREPARATION METHODS FOR COLLOIDAL GOLD 
Traditionally, gold colloids have been prepared 
by the reduction of gold chloride with a variety of 
substances such as phosphorus (Faraday, 1857; 
Zsigmondy, 1906), .formaldehyde (Zsigmondy, 1889), ethyl 
alcohol, tannic acid (Oswald, 1922), phosphorus in 
ether (Faulk and Taylor, 1971) and sodium citrate 
(Frens, 1973). Of these methods those of Zsigmondy and 
Frens have been shown to be useful for the production 
of monodisperse sols, whilst the use of phosphorus in 
ether by Faulk and Taylor has been shown to be useful 
in the production of colloids with an average particle 
diameter of less than 10nm. 
Another more recent approach has been the use of 
ultrasound (Baignet, 1980) with ethyl alcohol as a 
reducing agent. This method produces colloids with 
small diameters. 
Colloids produced for experiments discussed in 
this thesis were prepared according to the method of 
Frens, a more detailed account of this method is given 
in Chapter 5. 
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4.3 THE COLOUR OF GOLD SOLS 
4.3.1 General introduction 
The colour of gold sols in transmitted light is 
usually red, violet or blue, but may be yellowish brown 
or brown. The colour of the sols was once attributed to 
the presence of coloured compounds and although the 
blue colouration of certain sols may be attributed in 
part to the presence of aurous oxide the variation in 
colour of pure metal sols must be explained on physical 
rather than chemical grounds: 
4.3.2 Mie's theory of the colour of metallic sols 
Mie expressed the scattering and absorption 
cross sections of metallic sols as a power series in 
the size parameter 0( restricting the series to the 
first few terms. The truncation of the series restricts 
the Mie theory to small particles. The expansions are 
expressed in equations 4.1 and 4.2: 
Q abs = Aa2 + Ba 3 + 
Q sea = Da4 + 
Values of the coefficients 
reported by Pendorf (1962) are given 
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(4.1 ) 
(4.2) 
A, B, C and D as 
in Table 4.1: 
Table 4.1 
Values for the constants A to 0 in equations 4·.1 and 4.2 
Coefficient 
A 
B 
c 
o 
4nk 
General Case 
24nk 
(n2+k2)2 + 4(n2-k2) + 4 
20nk 
+------------------------
+ 4.8nk[7(n2+k2)2 + 4(n2-k2-S)]2 
[(n2+k2)2 + 4(n2-k2) + 4]2 
-192n2k2 
[(n2+k2)2 + 4(n2-k2) + 4]2 
~[(n2+k2)2 + n2 - k2 _2]2 + 36n2k2 
3 
Special Case 
of k=O 
o 
o 
o 
nand k are numerical coefficients of the refractive 
index of a gold sol. 
Using only terms below the fourth order in 
equations 4.1 and 4.2 several conclusions concerning 
Qabs and Qsca can be made: 
(i) The absorption and scattering efficiencies do not 
show the same dependence on the particle size parameter 
( ii) Both numerical coefficients of the 
refractive index, nand k, appear in Qabs and 
(iii) The efficiencies are functions 
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complex 
Qsca. 
of . the 
dimensionless variable a alone. 
(iv) For dispersions of uniform spheres, the entire 
wavelength dependence of the extinction is given by 
equations 4.1 and 4.2. 
4.3.3 Relation of the Mie theory to observations made 
on gold sols 
The observations made on the colloidal systems 
may be related to the Mie theory as follows: 
Using 
of the 
the values for the real and imaginary 
parts refractive 
according to data from 
Fig.4.l, it is possible 
index of gold in air and water 
van de Hulst (1957) as shown in 
to calculate values for the 
absorbance and scattering for va~ng size spherical 
gold particles. 
Data for particles of diameters 0.02, 0.05 and 
0.07 ~m as a function of the wavelength in air are 
shown in Fig. 4.2. The sum of the two cross-sections, 
the total extinction is shown. 
The magnitude and location of the maximum for 
each of the cross-section curves is informative. The 
location of the absorption curve changes relatively 
little with particle size as might be expected. The 
cross section for scattering, however, is practically 
negligible for the smallest of the particles increasing 
to be roughly 50 and 100% larger than the absorption 
for the larger particles. The scattering maximum also 
shifts to longer wavelengths as the particle size 
increases. This is a consequence of the fact that the 
efficiency depends on a, rather than separate values of 
diameter and wavelength. The wavelength at which total 
maximum absorbance occurs lies in the green, yellow and 
red portions of the spectrum, respectively, for 
the particles with diameters of 0.02, 0.05 and 0.07 
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Figure 4.1 
The real and imaginary parts of the complex refractive 
index of gold versus wavelength 
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~m. On the basis of complementary colours these would 
appear red, violet and blue respectively, which are 
colourations typical of colloids with such particle 
sizes. Thus, the Mie theory not only accounts for the 
colour of the dispersions, but shows how the colour 
displayed may be used to characterise the particle size 
of the dispersed phase. 
R = 0.02~m R = 0.05~m R = 0.07~m 
~ 3 
'" E 
u 
~ 
.... 42 90 c 
Q) 2 .~ u 
.~ ex 4-
4-
Q) 28 60 0-
u sea 
Cl 
c' 1 .~ 
s... 14 30 Q) .. 
..... abs ..... 
'" 
sea u VI-
450 550 650 450 550 650 450 550 
A air (nm) ... 
Figure 4.2 
The absorbance, scattering and total extinction for 
various size colloidal particles 
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4.4 FLOCCULATION OF COLLOIDS 
4.4.1 General introduction 
Flocculation is governed by the balance between 
the forces of attraction and repulsion and really 
cannot be understood in terms of either one alone. The 
full theory of stability which explains in broad 
concepts many complex observations is known as the 
Derjaguin, Landau, Verwey, Overbeck (DVLO) theory. 
The DVLO theory of colloid stability is best 
approached by considering curves which show the 
potential energy of a pair of colloid particles as a 
function of their separation. 'l'he potential energy 
results as a function of attraction due to van der 
Waals forces and repulsion due to overlap of the 
electrical double layers. 
Any quantitive comparison 
repulsive potential energies 
geometry be specified for the 
of attractive 
requires that 
particles. In 
and 
some 
this 
particular case it is easier to consider the case of 
interacting cubes as. the expressions are somewhat 
simpler than for the more realistic case of interacting 
spheres and no fundamental insights beyond those 
obtained by the consideration of this model are seen 
using the more complicated expressions. It, however, 
should be noted that in the case of cubes the 
expressions for potential energy are per unit area 
while those for spheres are total potential energy. 
Thus, in order to compare the two in the same units, a 
cross-sectional area in the gap between the cubes must 
be specified. 
For the case of two cubes with flat faces the 
energy of repulsion (~R) varies exponentially with the 
separation and the attraction (~A) varies with the 
square of the separation (Hiemenz, 1977). Using these 
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two observations it can be said that attraction will 
predominate at very small and very large separations 
(as separation - 0 ~R- constant and ~A ~- '" , as 
separa.tion __ '" "'A- 0 wi th ~R decr:easing more rapidly) 
and that for intermediate separations the details of 
the two contributions must be considered. 
Fig. 4.3 shows typical contributions of 
attraction (van der Waals) and repulsion (double 
repulsion) and the potential energy curve that 
resultant of the two components ( ~ net = ~R - $A 
1 
>, 
Cl 
'-QJ 
<:: 
LLI 
~ 
'" .~ ....,
<:: 
QJ 
...., 
0 
c.. 
Separation 
Figure 4.3 
Qualitative sketch of potential energy 
separation 
1. Double layer repulsion, 2. van der Waals 
3. Resultant- of 1 and 2. 
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layer 
is the 
versus 
Such a curve may show a maximum and two minima 
as in Fig. 4.3, although some of these features may be 
masked if one contribution greatly exceeds the other. 
The height of the maximum above ~ = 0 is called the 
energy barrier, the deeper minimum, the primary minimum 
and the more shallow one the secondary minimum. 
Although attraction predominates at larger distances, 
the secondary minimum is generally pre'sent but may be 
quite shallow. 
Considering qualitatively two particles 
diffusion on the approaching each other as a result of 
potential energy curve it can be said that: 
(i) If no barrier is present or the height of the 
barrier is negligible compared wi th thermal energy, then 
the net force of attraction will pull the particles 
together into the primary minimum, after which the two 
will behave as a single, kinetic unit, i.e., 
flocculation has occur~d. 
\ 
(ii) If the height of the potential energy barrier is 
appreciable compared to thermal energy, the particles 
are prevented from flocculating in the primary minimum. 
If the depth of the secondary minimum is small compared 
with thermal energy, then the particles will simply 
diffuse apart, i.e., the system is stable with respect 
to flocculation. 
(Hi) There may 
occurs in the 
much more easily 
primary minimum. 
be situations in which flocculation 
, 
secondary minimum, but these flocs are 
disrupted than those formed in the 
(iv) Generally speaking it is the height of the barrier 
that determin,es whether a colloid will be stable or 
undergo flocculation. 
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4.4.2 The effect of electrolytes on flocculation 
It has long been known that the addition of an 
electrolyte can cause a lyophobic colloid to undergo 
flocculation. The flocculation depends on both the 
concentration and charge of the electrolyte. 
Considering only the 
given electrolyte a 
concentration effect, £or a 
fairly sharply defined 
concentration is needed to induce flocculation. This 
concentration is called the critical flocculation 
concentration (CFC). One of the easiest tests for the 
CFC value for an aqueous colloid is to take a series of 
samples of the colloid (e.g. Sml samples) and to these 
add varying proportions of water and electrolyte 
solution (keeping the total volume constant). The 
degree of flocculation is then observed after a given 
period of time has elapsed. 
Using this method, accurate values for the CFC 
may be determined by firstly studying a whole range of 
electrolyte concentrations and then studying the 
specific range in which flocculation occurs. 
The CFC is dependant upon: 
(i) The time allowed to elapse before the evaluation is 
made; 
(ii) The uniformity, or more likely the polydispersi ty 
of the sample; 
(iii) The potential at the surface; 
(iv) The charge of the ions. 
One of the earliest generalisations about the 
effect of charge of the added electrolyte is the 
Schulze-Hardy rule (1900). This rule states that it is 
the charge of the ion of opposite charge to the colloid 
that has the principal effect on the .stability of the 
colloid. The CFC value for a particular electrolyte is 
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essentially determined by the charge of the counter ion 
regardless of the nature of the ion with the same 
charge as the surface. 
The effect of the addition of electrolytes to 
gold sols may be seen from a consideration of the 
structure formed in the presence of sodium chloroaurate 
solution: The charge on these particles is associated 
with the preferential adsorption of the anion (AuCli) 
which constitutes the inner layer of the double layer, 
the cation making up the outer diffuse layer (Fig. 4.4) 
Figure 4.4 
A diagrammatic representation of a colloidal 
micelle 
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gold 
On addition of electrolyte with a doubly charged 
cation, e.g., barium chloride, the doubly charged 
cation displaces the weakly adsorbed singly charged 
cation and locates itself in the inner layer as shown 
in Fig. 4.5. The result of this is that the thickness 
of the double layer is reduced due 
attraction of the doubly charged ion 
to the stronger 
by the inner 
layer. Hence the repulsive forces of the double layer 
are reduced due to a reduction in the size of the 
double layer and flocculation tends to occur . 
z 
". 
Figure 4.5 
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From the above consideration of how the addition 
of electrolyte affects the gold colloid it can be said 
that the CFC is reduced for a more strongly adsorbed 
ion. Although this is 
Schulze-Hardy rule, i.e., the 
electrolytes with varying 
in agreement 
precipi tating 
charge will be 
with the 
power of 
directly 
proportional to the charge, experimentally it has been 
shown that the rule is only qualitative. For example in 
the case of singly charged ions the sequences of 
effectiveness are: 
cations: 
Anions: 
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4.5 PROTECTION OF GOLD COLLOIDS FROM FLOCCULATION 
It is possible to "protect" gold colloids from 
coagulation by electrolytes by the addition of a 
negatively charged hydrophil~ or "water soluble" sol. 
This protective action varies widely with different 
substances and in an attempt to standardise data 
Zsigmondy devised 
determination of 
an experimental protocol for the 
"gold numbers" (Zsigmondy, 1906), 
which acts as a measure of- the relative protective 
power. The "gold number" is defined as the number of 
milligrams of an electrolyte added to a given gold sol 
which just 
red to blue 
fails to prevent the change in colour from 
on addition of lcm of 10% sodium chloride 
solution. When determining gold number values it is 
particularly important to standardise the experimental 
procedure as values vary with p~icle size, pH and 
dispersion of the protecting agent. 
The theory of protective action 
Three po~bilities arise in a typical case of 
protection of a gold colloid by a protecting agent: 
(i) If the particles of the protecting agent are 
smaller and more numerous than the gold particles 
mutual adsorption will result in the formation of a 
protecting film on the gold (F ig . 4.6 (a) ) , thereby 
minimising the coagulating action of the electrolyte. 
(ii ) If the particles are of the same size an 
arrangement similar to that in (i) is possible. 
However, as there are fewer particles to be distributed. 
over the gold surface a lower protection is achieved. 
(iii) If the protecting particles are much larger than 
the gold particles, the gold particles are adsorbed 
onto the surface of the protecting agent (Fig. 4.6(b». 
In this case if the number of gold particles is great 
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relative to the number of protecting particles, they 
may be so crowded onto the surface that coagulation 
occurs. 
~~~ 
~ WJ 
a ~@1DJ> 
Colloidal Gold Particle 
b o Protecting Agent 
Figure 4.6 
A diagramatic representation of the protective action 
of varying sized particles 
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CHAPTER FIVE 
COLLOIDAL GOLD AS A LABEL IN IMMUNOASSAY 
AND THE IMMUNOASSAY OF ALBUMIN 
5.1 MATERIALS AND GENERAL METHODS 
5.1.1 Materials 
Material Source of supply 
Ammonium chloroaurate BDH Chemicals Ltd., 
Atherstone, Worcs. 
Anti-human albumin 
Anti-rabbit IgG 
Buffer tablets 
Chloroauric acid 
Chloroform 
di-Sodium hydrogen 
orthophosphate 
Formvar 
Human serum albumin 
Nitric acid 
Phosphoric acid 
Polyethylene glycol 
Potassium carbonate 
Sodium chloride 
Sodium di-hydrogen 
orthophosphate 
Standard human 
serum 
Mercia-Brocades Ltd., 
Weybridge, Surrey. 
Sigma (London) Chemical 
Co. Ltd., Poole, Dorset. 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
BDH Chemicals Ltd., 
Atherstone, Worcs. 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
BDH Chemicals Ltd., 
Atherstone, Worcs. 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
Sigma (London) Chemical 
Co. Ltd., Poole, Dorset. 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
Sigma (London) Chemical 
Co.Ltd., Poole, Dorset. 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
Fisons Scientific Apparatus, 
Loughborough, Leics. 
Fisons Scientific Apparatus, 
Loughborough,Leics. 
The Boehringer Corporation, 
London. 
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Tri-sodium citrate Fisons Scientific Apparatus, 
Loughborough, -Leics. 
5.1.2 General methods 
Buffer preparation: 
Phosphate buffer (O.lM) containing 0.2 mg/ml 
polyethylene glycol (mwt. 20,000) was prepared from 
di-sodium hydrogen orthophosphate and sodium 
di-hydrogen ortlophosphate. 
preparation of collodion coated grids for transmission 
electron microscopy (TEM): 
Grids for TEM were coated using the following 
procedure: 
(i) A 10% Formvar solution in chloroform was prepared 
and used to fill to 3/4 height a tall jar. 
(ii) A microscope slide was cleaned with alcohol, 
allowed to dry and then coated with a small quantity of 
Teepol. 
(iii) The prepared slide was _dipped vertically into the 
Formvar solution, removed and allowed to drain in the 
chloroform rich atmosphere above the solution. 
(iv) The slide was then allowed to dry vertically over 
filter paper. 
(v) Using a scalpel a rectangle was cut in the film 
parallel to the slides edges. 
(vi) The slide was then breathed on to loosen the film 
and film floated onto a clean water bath, the slide 
being immersed at a 30° angle to"flat off" the film. 
(vii) The film was then observed in reflected light to 
judge its thickness: 
GOLD film too thick 
SILVER/SILVER GREY correct thickness 
(viii) Grids were then floated onto the films judged to 
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be of the correct thickness and gently pressed with 
forceps to ensure good contact. 
(ix) The coated grids were then removed from the water 
bath using a piece of lint free tissue. 
(x) The dried grids were stored in a petri dish prior 
to use. 
pH measurements on colloidal solutions: 
pH measurements were made following the addition 
of two drops of 1% polyethylene glycol (mwt. 20,000) to 
10ml of colloidal gold to prevent flocculation of the 
colloid by the potassium chloride of the pH electrode. 
preparation of glassware: 
Glassware was prepared by overnight 
1% nitric acid followed by washing 
soaking in 
with triply 
distilled water, which had been collected into glass. 
Preparation of aqueous gold standards: 
A 1000 ppm stock solution of gold solution was 
prepared by dilution of 1.8ll0g of ammonium 
aurochlorate in 1 litre of triply distilled water that 
had been collected into glass. Serial dilutions were 
subsequently made to produce the concentrations 
required for atomic spectroscopy. 
preparation of albumin for adsorption experiments: 
The albumin was prepared free from electrolytes 
by dialysis against distilled water for a period of 
three days. 
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5.2 INSTRUMENTATION 
5.2.1 Absorbance measurements 
Absorbance measurements at fixed wavelengths 
were made on a Kontron Uvikon 10 spectrometer (Kontron 
Analytical, St. Albans). 
5.2.2 pH measurements 
The pH values of the solutions used in the 
experimental work were measured on a pye Unicam Model 
290 pH meter (pye Unicam Ltd., Cambridge) fitted with a 
potassium chloride electrode. The instrument response 
was checked before use with buffer solutions made from 
pH 4.0, 7.0 and 9.2 buffer tablets. 
5.2.3 Centrifugation 
using 
Centrifugation 
a Clandon T 52.~ 
at 2,500 rpm was carried out 
centrifuge fitted with a 8 x 
50ml annular "rotor. At 11,500 rpm centrifugation was 
carried out using a M.S.E. high speed centrifuge. 
5.2.4 Atomic absorption measurements 
Atomic absorption measurements were carried out 
using a pye Unicam SP9 spectrometer fitted with a 
graphite furnace and SP9 video furnace programmer. Data 
were recorded on a SP9 computer. An autosampiing 
facility was available with the spectrometer. 
5.2.5 Transmission electron microscopy (TEM) 
Electron micrographs were recorded using a 
A.I.E. EM6B electron microscope. 
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5.3 COLLOIDAL GOLD AS A LABEL IN IMMUNOASSAY 
5.3.1 preparation of colloidal gold 
Colloidal gold was prepared by the reduction of 
chloroauric acid with sodium citrate according to the 
method of Frens (1973). Table 5.1 gives details of the 
amounts of chloroauric acid and sodium citrate 
required to produce colloids of a given particle 
diameter and associated colour (Chapter 4). 
Table 5.1 
Data by Frens on the production of colloidal gold 
Amount 10% Amount 1% Colour Diameter 
HAuCl Na Citrate (nm. ) 
(ml. ) (ml. ) 
50 0.75 Orange / red 25 
50 0.50 Red 40 
50 0.30 Dark red 70 
50 0.20 Violet* 100 
*with a yellow Tyndall effect of scattered light 
colloidal solutions prepared by this method, 
i.e., the reduction of boiling chloroauric acid 
solution with aqueous tri-sodium citrate are shown in 
Fig. 5.1. 
Batch colloidal gold preparation for use in the 
development of an immunoassay procedure was carried out 
as follows: One litre of triply distilled water 
containing O.lg chloroauric acid was brought to boiling 
point and to this added 25ml of freshly prepared 1% 
aqueous tri-sodium citrate solution. Boiling was 
continued through the blue phase of nucleation to the 
red phase of colloid formation. 
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The colloid produced was red in colour and had an 
average particle diameter of 20 - 22 nm. (as determined 
by TEM). The particles were monodisperse. 
5.3.2 Analysis of colloidal gold by TEM 
Analysis of the colloidal gold solutions shown 
in Fig 5.1 was carried out as follows: The colloidal 
solution was dropped onto a coated copper grid (section 
5.1.2) and allowed to settle for several minutes. 
Excess solvent was then removed by gentle blotting with 
filter paper and the grid allowed to dry. The grid was 
subsequently placed into the microscope and viewed. An 
accelerating voltage of 60kV was used and photographs 
were taken at a magnification of 60,000 X. Results 
obtained for experimentally prepared colloids are shown 
in Fig. 5.2. 
As can be seen from the micrographs monodisperse 
particles are obtained for particle diameters up to and 
including 70nm. However, at larger particle diameters 
the particles tend to clump and loose their 
monodispersity. 
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Diameter 25nm (60 OOOX) 
Diameter 40nm (60 OOOX) 
Figure 5.2 
TEM pictures of colloidal gold 
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Diameter 70nm (60 OOOX) 
Diameter 100nm (60 OOOX) 
Figure 5.2 continued 
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5.3.3 The construction of an adsorption isotherm for 
albumin onto colloidal gold 
In order to determine the amount of a given 
protein required to protect a given colloidal gold 
solution from coagulation by electrolytes an adsorption 
isotherm may be constructed (Geoghegan and Ackerman, 
1977) . 
Using human serum albumin as the chosen protein, 
an isotherm was constructed as follows: lml. of albumin 
solution (varied concentrations) was added to 5ml. of 
colloidal gold (pH 7.0, just above the pI value for 
albumin) and mixed rapidly. After one minute, lml of 
10% sodium chloride was added in order to flocculate 
any unprotected colloidal particles. The absorbances of 
the solutions were then measured following five minutes 
incubation. (The absorbance of the solution increased 
with the colour change of red to blue on flocculation). 
The results obtained for albumin are given in Table 5.2 
and Fig. 5. 3. 
Table 5.2 
Results for the adsorption of albumin onto colloidal 
gold 
Amount of albumin lcm Abs 
(ug ml -1 ) 580nm 
100 0.960 
150 0.795 
250 0.498 
300 0.462 
500 0.457 
750 0.459 
1000 0.487 
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o 
From the results in Table 5.2 and Fig. 5.3 it 
can be seen that the cOlloidal gold is completely 
protected by albumin at a concentration of 300 ~g ml- 1 • 
It was found that this value did not vary significantly 
between batches of colloidal gold. 
5.3.4 The construction of a pH isotherm for the 
adsorption of albumin onto colloidal gold 
The effect of pH on the adsorption of albumin 
onto colloidal gold was investigated by the 
construction of an isotherm similar to that for 
adsorption. In this case the concentration of albumin 
was kept constant at 300 ~ g ml- 1 , and the pH varied. 
The pH values of the colloidal gold solutions 
were adjusted using 0.2M potassium carbonate or 
phosphoric acid. 
The results obtained for the pH isotherm are 
given in Table 5.3 and Fig. 5.4. 
Table 5.3 
Results for the pH isotherm for adsorption of albumin 
onto colloidal gold 
lcm 
pH Abs 
580nm 
4.0 1. 015 
, 
4.5 0.749 
5.0 0.503 
6.0 0.451 
7.0 0.410 
8.0 0.452 
9.0 0.472 
10.0 0.625 
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As can be seen from Table 5.3 and Fig. 5.4 the 
optimum pH value for labelling of the colloidal gold is 
pH 7.0. 
5.3.5 Batch preparation of colloidal gold labelled 
albumin 
Using the results from the two isotherms the 
optimum concentration of albumin for adsorption was 
taken to be 300~ g albumin per 5ml of colloidal gold 
and the optimum pH value 7.0. The following procedure 
for batch labelling was used: l2ml of 1 mg ml l albumin 
was added dropwise but rapidly to 200ml of colloidal 
gold whilst gently stirring. The two were allowed to 
mix for one minute, then 2ml of 1% polyethylene glycol 
(mwt. 20,000) was added to prevent aggregation of the 
colloidal gold - albumin complex. The complex was then 
centrifuged at 1,500 rpm for 20 minutes to remove any 
large agglomerates prior to collection of the complex 
by centrifugation at 11,500 rpm for one hour. Removal 
of any remaining traces of albumin was then achieved by 
suspension of the complex in phosphate buffer and 
re-centrifugation at 11,500 rpm for one hour. The 
complex was subsequently re-suspended in O.lM phosphate 
.buffer containing 0.2mg ml- l polyethylene glycol, any 
large undispersed particles being removed by 
centrifugation at 1,500 rpm for 20 minutes. 
5.3.6 Titration of the colloidal gold - albumin complex 
against anti- albu~in 
Titration of the complex against anti-albumin 
was carried out using the double antibody technique: A 
sample of the complex (2ml) was incubated with 0.2ml of 
varying concentrations of anti-albumin (antiserum 
raised in rabbits) for a period of one hour, and then 
reacted with anti-rabbit IgG (second antibody) to cause 
precipitation. Following precipitation the 
centrifuged at 1,500 rpm to remove any of 
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samples were 
the complex 
bound 'to antibody and 
measured at 580nm. 
results obtained. 
the absorbance of the supernatant 
Table 5.4 and Fig. 5.5 show the 
Table 5.4 
Results for the titration of the colloidal gold 
albumin complex against anti-albumin 
Dilution of 
anti-albumin 
1:50 
1:100 
1:200 
1:300 
1:400 
1:500 
no 1st antibody (1:200 2nd) 
no 2nd antibody (1:200 1st) 
lcm Abs 
580nm 
0.060 
0.123 
0.362 
0.573 
0.767 
0.793 
0.785 
0.781 
Absorbance of the colloidal gold complex 0.896 
As can be seen from Table 5.4 and Fig. 5.5 
titration of the colloidal gold-albumin complex against 
anti-albumin shows good antibody recognition of the 
complex, which suggests that the complex should be 
useful in the development of an immunoassay procedure. 
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FIG. 5.5. TITRATION OF COLLOIDAL GOLD-ALBUMIN AGAINST ANTI-ALBUMIN 
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5.3.7 The effect of human serum on the colloidal gold -
albumin complex 
Table 5.5 shows the effect of the addition of 
human serum at a level of 1 : 100 on the absorbance of 
the complex at 580nm. As can be seen from the table the 
complex is stable in the presence of serum for a period 
of time for it to be useful in immunoassay. 
Table 5.5 
The effect of human serum on the colloidal gold -
albumin complex 
Time after addition lcm Abs 
580nm 
no addition 1. 006 
immediately 0.991 
1 hour 0.982 
2 hours 0.976 
5 hours 0.951 
24 hours 0.953 
48 hours 0.896 
1 week 0.876 
5.3.8 Development of an immunoassay procedure for 
albumin 
Experiments to develop an immunoassay procedure 
for albumin using colloidai gold labelled albumin were 
carried out using the double antibody technique: The 
dilution of anti-albumin was kept constant at 1 200 
with second antibody matched by titre and standards 
were prepared in 
standards (0.2ml) 
aqueous solution. The albumin 
were added to the labelled albumin 
along with the. anti-albumin and the 
the antibody titration repeated. 
this method are shown in Table 5.6 
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procedure as 
Results obtained 
and Fig. 5. 6. 
for 
for 
FIG. -5.6 IMMUNOASSAY STANDARD CURVE FOR ALBUMIN 
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Table 5.6 
Immunoassay results for aqueous albumin standards using 
colloidal gold labelled albumin 
Albumin concentration 
(mg mr 1 ) 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
lcm 
Abs 
580nm 
0.078 
0.237 
0.423 
0.549 
0.642 
0.699 
From the results in Table 5.6 and Fig. 5.6 it 
can be seen that competition for anti-albumin does 
occur between aqueous albumin standards and the 
colloidal gold labelled albumin. This reaction was 
repeated 
labelled 
with various batches of colloidal 
albumin and found to be reproducible. 
gold 
This immunoassay procedure was subsequently used 
in the analysis of a real sample: The sample chosen for 
analysis was standard human serum. A 1 : 200 dilution 
of the serum sample was calculated from the certificate 
value t~ contain 0.29 mg mr 1 albumin. A 1 : 100 and a 
1 200 were thus used as samples for immunoassay and 
the results obtained are shown in Table 5.7. 
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Table 5.7 
Analysis of standard human serum using the immunoassay 
procedure developed using colloidal gold labelled 
albumin 
lcm 
Sample for immunoassay Abs 
580nm 
1 100 human serum 1.106 
1 100 human serum 1.109 
1 200 human serum 0.547 
1 200 human serum 0.551 
.. -
0.3 mg standard 0.551 
0.3 mg standard 0.549 
As can be seen from the results in Table 5.7 the 
method is able to accom~ate the analysis of the human 
serum sample, The presence of the diluced serum se~med 
not to affect the immunoassay procedure. 
This procedure using 'calorimetric detection 
gives a detection limit of 0.1 mg ml -1 albumin. However 
this may be improved 1000 fold by the use of atomic 
spectroscopy (see section 5.4.2). 
5.3.9. The potential use of colloidal gold labelled 
antibodies in immunoassay 
Using the same method of labelling as described 
in earlier for the colloidal gold labelling of albumin, 
anti-albumin antibodies were labelled. Experiments 
using these labelled 
that they remained 
Immunoassay methods 
therefore, must become 
labelling approach. 
antibodies subsequently showed 
viable following labelling. 
using labelled antibodies, 
a possibility with this type of 
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5.4 THE USE OF ATOMIC SPECTROSCOPY IN IMMUNOASSAY USING 
COLLOIDAL LABELS 
5.4.1 Instrumentation for atomic spectroscopy in 
immunoassay 
Atomic absorption spectroscopy with 
electrothermal atomisation is particularly useful in 
this type of application as it requires a small sample 
volume, has low limits of detection and, using a 
carefully chosen ashing programme, is virtually free 
from background effects due to serum. 
The central element in the electrothermal 
atomiser is the cuvette into or onto which the sample 
is placed and from which it is atomised into the 
optical beam of the spectrometer. Atomisation is 
achieved by heat transfer to the sample from the 
cuvette which is heated ohmically. Typically a cuvette 
will have a resistance of the order of 10 milliohms, 
hence when a voltage of e.g. 7 volts is applied across 
the ends of the cuvette a current of several hundred 
amps will flow. 
The cuvette is usually constructed of graphite 
as it has good thermal chemical and mechanical 
properties in that it has good thermal conductivity, a 
high melting point, is chemically inert, has low levels 
of contaminants and its machineability is such that 
furnace production is easy. 
The Pye Unicam 
experiments described 
furnace constructed of 
SP9 system 
later employs 
Ringsdorff RWO 
as used in the 
a Massman type 
type graphite. 
This type of furnace consists of a cylinder of graphite 
through which the sample is introduced via a small hole 
(c.a. 2mm diameter) in the middle of the cylinder (Fig. 
5.7). The dimensions are fixed 
and are dependent upon 
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by computer calculations 
the following basic 
requirements: (i) the bore must be sufficient not to 
attenuate the light beam or to allow emissions from the 
hot walls to reach the photomultiplier, (ii ) the 
central hot zone must hold a 60 ].11 sample, (iii ) tube 
thickness must be a compromise between the power 
requirement to allow a temperature rise to 3000 °c and 
physical strength, (iv) the injection hole must be 
large enough to accomArlate standard pipettes but small 
enough to preserve the isothermal environment, (v) the 
end flanges must have a large surface area to give good 
electrical contact but be thin enough to reduce the 
cooled mass of graphite hence reducing condensation. 
o 
Figure 5;7 
A cross section of the SP9 graphite tube 
The furnace head used in this system is of the 
closed head design with a normal gas flow. A 
diagramatic representation of the furnace head showing 
furnace mountings and gas and sensor systems is shown 
in Fig. 5.8. 
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o 
, 
Figure 5.8 
The SP9 furnace head. 
Control of the heating of the sample may be 
carried out in two ways: (i) voltage feedback control 
or (ii) temperature feedback coritrol (Lundgren et.al., 
1974). In the former case a voltage calculated to 
produce a given temperature when applied to the 
graphite furnace is employed, whilst in the secorid case 
the maximum voltage is applied until the op~ical 
feedback sensors indicate that the required temperature 
has been reached. The major diadvantage of the voltage 
feedback control technique is that the temperature 
risetime is heavily dependent on the final temperature 
compared with the temperature feedback control system 
(Fig. 5.9), a factor which tends to lead to a loss of 
analytical sensitivity. 
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Temp °C 
3000 
2000 
1000 
1 2 3 4 5 1 2 3 4 
Time (seconds) 
Figure 5.9 
The effect of final temperature on temperature risetime 
using: 
(i) Temperature feedback 
control 
(ii) IVoltage feedback 
control 
In the analysis of the colloidal gold-albumin 
complex the temperature 
used because with this 
feedback control system was 
system where the rate of 
temperature rise is virtually constant irrespective of 
the final temperature the following advantages are 
generally observed: (i) higher analytical sensitivity, 
(ii) lower atomisation temperatures, (iii) longer 
cuvette life, (iv) close temperature control and hence 
. , 
more efficient ashing procedures, (v) reduced cycle 
times. 
5.4.2 Analysis of the colloidal gold-albumin complex by 
atomic absorption spectroscopy 
An investigation of the operating parameters of 
the Pye Unicam SP9 system was carried out using 
gold standards. The best conditions for drying, 
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aqueous 
ashing 
5 
and atomisation were investigated as follows: The 
drying time was chosen to completely remove the solvent 
from the sample without boiling the solution which may 
cause spluttering of the sample over the tube walls. 
The ashing temperature was set at the level where a 
maximum temperature could be applied to ash the sample 
without loss due to atomisation during the ashing 
phase. Atomisation was carried out at the lowest 
temperature seen experimentally to give maximum signal, 
lower temperatures prolonging the tube lifetime. 
Conditions chosen for the analysis of gold are 
shown in Table 5.8. 
Programme for the analysis of gold by CFAAS 
Programme Phase Temp. 
°c 
dry 120 
ash 400 
*autozero 
atomise 2500 
tube clean 2800 
Time 
sec. 
50 
30 
3 
Ramp 
rate 
9 
7 
0 
o 
Other 
conditions 
output to 
computer, 
temperature 
feedback 
control 
*autozero 
tube 
zero set with no voltage applied to the 
A calibration curve for aqueous gold standards 
using the programme in Table 5.8 is shown in Fig. 5.10 
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Analysis of the colloidal gold-albumin complex 
was carried out following dilution using the programme 
developed for the aqueous gold standards. Table 5.9 
shows the signals obtained and Fig. 5.11 analysis of 
the gold content using the calibration curve for 
aqueous gold solutions. 
Table 5.9 
Analysis results for the colloidal gold-albumin complex 
by CFAAS. 
Dilution of 
the complex 
1:10 
1:100 
1:500 
1:1000 
Peak a'rea 
off range 
0.475 
0.231 
0.059 
ppm Gold 
0.100 
0.094 
0.047 
0.009 
From the results of the colloidal gold-albumin 
complex by CFAAS it can be seen that the detection 
limit for the complex can be increased 1000 fold over 
that using calorimetric: methods, giving the potential 
of detecting albumin at a level of 10 mg ml- 1 • 
This detection method also has the advantage 
that it is not affected by the presence of serum due to 
the dilution factors used 
procedures associated with 
serum matrix 'by burning. 
in immunoassay, and ashing 
CFAAS, which remove the 
An investigation of the effectiveness of the 
ashing procedure used in the gold analysis was made 
using standards containing human serum at a 
concentration of 1:100. The calibration curve obtained 
for this analysis (Fig. 5.12) was linear over the range 
o to 0.1 ppm. However, a 4 - 5% loss of absorbance 
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signal compared to the analysis of aqueous solutions 
was observed. 
Using the SP9 system with autosampling it was 
possible to run 38 samples without operator 
intervention, at a throughput rate of 20 samples per 
hour. 
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CHAPTER SIX 
CONCLUSIONS AND COMMENTS 
6.1 A COMPARISON AND EVALUATION OF THE TWO APPROACHES 
TO IMMUNOASSAY DISCUSSED IN THE THESIS 
Of the two approaches to immunoassay 
investigated in this thesis, i.e., the use of a 
fluorescent terbium-transferrin complex and the use of 
colloidal particles as labels, experimentally the 
colloidal labelling was the most sucessful. 
Considering the two approaches in general terms 
the method of SPIA, i.e., the use of colloidal 
particles as labels appears to offer several advantages 
over MIA, i.e., the use of the terbium transferrin 
complex. These reflect the advantages that Leuvering 
put forward in his paper introducing the SPIA method 
(Chapter 1) and include the physical method of 
adsorption for labelling, low limits of detection 
associated with the detection of many millions of atoms 
in a colloidal particle compared to the two terbium 
atoms associated with each molecule of transferrin and 
the possibility of multicomponent analysis. The 
advantage of the labelling method can be seen in both 
the experimental ease of carrying out the labelling 
procedure and the way in which antibodies may be 
labelled and still retain their antigen binding 
properties. Multicomponent analysis also becomes a real 
possibility with this method as using atomic absorption 
spectroscopy with electrothermal atomisation, two 
components, e.g., gold and silver may be determined in 
the same solution without significant interference. No 
doubt using plasma emission spectroscopy si'multaneous 
determinations may be made. 
Although in terms of multicomponent analysis the 
lanthanide-transferrin complexes offer no possibilities 
because the complexes other than that with terbium tend 
to be non-fluorescent it may be possible to develop 
simultaneous assays with other lanthanide complexes. 
This would involve complexes of two lanthanides, e.g., 
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terbium and europium, 
solution utilising 
which may be analysed in the same 
the specificity possible with 
selective excitation and/or emission wavelengths to 
detect only one component. 
Despite the obvious advantages of SPIA and the 
favourable experimental evidence it may well not be as 
acceptable a procedure as a fluorescence based assay 
such as the terbium-transferrin assay in the clinical 
analysis field. This and other factors concerning the 
future of irnrnunoassays with metals as labels are 
discussed in Section 6.2. 
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.6.2 FUTURE PROSPECTS FOR THE USE OF METALS AS LABELS IN 
IMMUNOASSAY 
Although the method of SPIA offers certain 
desirable features in 
immunoassay procedure 
unlikely that it will 
terms of a non-isotopic 
(Section 6.1) it seems somewhat 
become a method of particular 
the clinical analysis field. This 
the fact that the method of 
interest for use in 
may be attributed 
detection required 
CFAAS, which is not 
to 
for the most sensitive assays, is 
a particularly popular or widely 
available technique in the clinical environment. The 
general cost of such an instrument, i.e., in the region 
of £18,000, is also such that it is unlikely that it 
would be possible to introduce it into the clinical 
analysis environment for what initially would be a new 
and limited field. Commercial manufacturers would be 
unlikely to introduce the technique for a broad 
spectrum 
had been 
of compounds before a small area of interest 
fully investigated. 
Even though attempts to develop an immunoassay 
procedure using the fluorescent terbium-transferrin 
complex discussed in this thesis were unsuccessful this 
type of procedure is one which would be somewhat more 
acceptable and easily incorporated into the clinical 
laboratory and~thus an area that is undergoing much 
investigation. The large number of transition metal 
complexes and specialised fluorescence techniques 
available (see dis~ussion in Chapter 1) offer great 
scope for investigation and indeed many methods are 
being studied in the research environment. Commercial 
methods at present are few and generally rather 
complicated as demonstrated by the LKB "OELFIA" system. 
This particular assay involves the use of 
antibodies labelled with a weakly fluorescent europium 
chelate and a solution termed an "enhancement 
solution", Which, on addition to the europium 
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chelate-labelled antibody, causes dissociation of the 
europium ion from the chelate and formation of a second 
highly fluorescent europium chelate, the fluorescence 
intensity of the latter being ca. 1,000,000 fold that 
of the original. 
Dissociation Enhanced Lanthanide FIA's 
(DELFIA's) are 
fluoroimmunoassays 
either 
based 
solid 
on the 
phase, 
direct 
two site 
sandwich 
technique, with an excess of europium second antibody, 
or solid phase competative binding fluoroimrnunoassays 
in which solid phase antigen (bound to carrier protein) 
and free antigen compete for a limited number of 
europium-labelled antibody binding sites. Many DELFIA's 
involve the use of monoclonal antibodies, which greatly 
increases the assay specificity. 
Advantages of the technique include the fact 
that the sensitivity of time resolved fluorescent 
measurements for europium is as high as 5 x lcr 14 M. The 
chelates also have long fluorescent decay times of 10 ~ 
100 11 s. Hence when this fluorescence is measured after 
a certain period of time has elapsed from the moment of 
excitation, the analytical interference from scattered 
light and short (1-20ns) fluorescence resulting from 
biological materials can be virtually eliminated. Other 
properties of the lanthanide chelates that contribute 
to the high sensitivity of DELFIA's are their very 
large Stokes shift (difference in wavelength between 
the excitation and emission spectral peaks), very 
narrow emission maxima' and their relatively large 
excitation region. However, in this 
need to remove background fluorescence 
as scattered light will be zero for 
shift value. 
, 
assay there.is no 
wi th time delays 
a large Stokes 
In general terms the fate of immunoassays using 
metals as labels could, therefore, be said to be 
dependent on the development of a procedure.which is 
Page 126 
uncomplicated and' utilises detection methods available 
in the clinical laboratory. 
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6.3 RECENT NOVEL APPROACHES TO NON-ISOTOPIC IMMUNOASSAY 
A new approach that is of interest is the method 
of assay termed "Immuno Blot". This method involves th~ 
detection of antigen after it has been bound to a 
nitrocellulose membrane. Detection is achieved by 
incubation with first antibody specific to the antigen 
under investigation, washing to remove excess antibody 
and subsequent incubation with a second antibody 
conjugate containing a substrate capable of colour 
production e.g., horseradish peroxidase. 
The binding of the antigen to the nitrocellulose 
membrane may be carried out in several ways: (i) "Dot 
Blotting" (Hawkes et. al. , 1972), this is where the 
antigen is spotted directly onto the membrane; (ii) 
"Electro Blotting" (Burnette, 1981), here blotting is 
carried out following electrophoretic separation on 
polyacrylamide or agarose gel; (iii) Colony or plaque 
lifting (Erlich et.al., 1978), which is achieved by 
overlaying a phage plate or lysed bacterial colony with 
the nitrocellulose membrane to bind expressed proteins. 
In all cases following blotting all the remaining 
unbound sites are blocked with a non-reactive protein, 
e.g., gelatin. 
potential of this 
by the Bio-Rad 
IgG Horseradish 
type of assay 
Inunun-Blot 
is 
Goat 
Peroxidase Conjugate 
The 
demonstrated 
Anti-Rabbit 
(GAR-HRP) Assay Kit (Bio-Rad Laboratories, Richmond, 
C.A.). which has a detection limit of 100 pg for a 
selected purified protein. 
This method may be of interest when considering 
metals as labels in non-isotopic inununoassay, as 
instead of using a double antibody technique, it may be 
possible to use coloured colloidal labelled antibodies 
as markers. Also with fluorescence detection this 
method may prove useful as absorbed / adsorbed 
'Page 128 
materials may have increased fluoresence over that _ in 
solution as solvent quenching effects may be reduced. 
Page 129 
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